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ABSTRACT
Drugs tested on animal models do not always produce the same results in
humans; a reliable in vitro lung model can bridge the divide between the two.
Because the alveolus is a target for several drugs, an alveolar model can be a
platform for both designing drugs and studying lung diseases. A model should
allow for gas exchange, growth of primary alveolar epithelial cells, extracellular
matrix production, and have similar mechanical properties to alveoli, creating an
environment conducive to normal metabolic activity and cellular responses.
Existing artificial alveolar models that use polymeric membranes to sustain lung
cells are limited by the necessary strain profile and the ability to maintain primary
human alveolar cells. We are engineering an alveolus-on-a-chip device that
simulates complex functional human alveoli, including the thin microporous
viii

alveolar barrier and the three-dimensional cyclic stretch induced by breathing
movements. The design of this platform is optimized for robust fabrication, ease in
cell culture manipulation, fluidic management and stretch activity. Furthermore, we
are investigating two main types of primary alveolar cells culture in the alveoli
which truly mimic the alveolar population. Our results suggest a use of this artificial
alveolus in the development of an effective platform for rapid drug screening and
pulmonary disease research.
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Mimicking the Physiology of Human Alveolus

Introduction
Alveoli are responsible for exchanging gas in the human body. They are the
distal region of the lung and have been shown to be the target site for various lung
infections (6). Sever damage in alveolar-capillary unit is one of the pathology for
Acute Respiratory Distress Syndrome (ARDS) (7). Each year in the United States
20,000 people are affected by ARDS which causes almost 50% fatality and leaves
the other half of the affected population with life-long complications. Infant
respiratory distress syndrome, emphysema, pneumonia, chronic bronchitis, etc.
are other diseases resulting from the damage or the dysfunctional alveoli. Effective
treatments for these diseases are limited due to the lack of understanding the exact
underlying mechanisms. To improve the treatments and to develop effective drugs
against the various alveolar diseases it is imperative to understand the physiology
and molecular signaling of alveoli.
The traditional approach to investigate alveolar physiology, diseases, and
cellular response is culturing animal alveolar cells (8), human alveolar cell lines (9)
and in some special cases primary alveolar cells collected from patients in a twodimensional (2D) culture system (10, 11). But it is possible that the 2D system can
give deviated cellular responses compared to in vivo responses as the captured
physiology in a dish is very different from the living human body (12-14). Emerging
microfluidic technology has provided bioengineers an essential tool to construct
physiologically relevant micro scale organs-on-a-chip (OOC). These technologies
1

enable the construction of an alveolus-on-a-chip (AOC) that captures the threedimensional microphysiology of the human alveolus. In this chapter, the physical
and mechanical properties of human alveoli will be highlighted along with the basic
components of an alveolar microphysiological system. The evaluation of the
functionality of existing AOC systems will be discussed focusing on some specific
criteria such as cell culture substrate, reliable and reproducible fabrication of
microporous membrane, and exposure of mechanical stimuli in the system. Further
research that needs to be done to make the advancement in the current field will
be summarized at the end of the chapter.

Human alveolar physiology
1.2.1. Structural properties
Alveoli were first described by The French anatomist Rossignol, in 1846, as
he found the resemblance of lung tissue with honeycomb (in Latin, alveoli = the
cells of honeycombs) (15). Approximately 300 - 400 million alveoli that are
responsible for gas exchange can be found in an adult human body. It has been
estimated that approximately 87% of the total lung volume is alveolar, 6% of which
is composed of tissue, and the remainder of which is gas (16). Each of this alveolus
has an average diameter of 250-300 µm (17). The inner structure is comprised of
a thin fluid layer, an epithelial cell membrane, an epithelial basement membrane,
an interstitial space, a capillary basement membrane and a capillary endothelial
cell membrane (Figure 1.1) (18). The thin layer composed of surfactant and
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alveolar fluid and the ratio of gas to fluid in alveolar space is 900:1(19). Different
architectural values of an alveolus are listed in Table 1.1.
1.2.2. Cell types
The alveolar cell population comprises of alveolar epithelial cells,
mesenchymal cells, endothelial cells and, macrophages (Figure 1.2). Two main
cell types: The Alveolar Type I (ATI) and Alveolar Type II (ATII) cell represents the
alveolar epithelium. The very thin (about 0.1 µm) squamous cell that fused to the
basement membrane are alveolar type I cells and plays a vital role in gas exchange
(20, 21). ATI cells are small, cuboidal cells that comprise around 60% of the total
pulmonary alveolar epithelium cell population (22). ATII cells secrete antimicrobial
products such as complement, lysozyme, and surfactant proteins (23). Surfactants
are mostly a lipid complex (24) decrease the surface tension between the thin
alveolar walls and stop alveoli from collapsing during expiration. These cells are
connected to the epithelium and other adjacent cells by tight junctions. The third
type of caveolated alveolar epithelial cells or brush cells were identified in the
alveolar lining during some human disease state, although their function is not fully
understood (25).
Five types of mesenchymal cells are identified within the alveolar
interstitium: Fibroblast, interstitial cells, smooth muscle cells, pericytes, and
myofibroblast. Fibroblast are elongated cells with numerous cytoplasmic
processes, interstitial cells are also elongated found wrapped around the
capillaries, myofibroblast can be found peripherally to the alveolus and
3

hypothesized that they participate in lung contraction during mechanical stimuli,
pericytes can be found on the endothelial basement membrane and smooth
muscle cells can be occasionally found in alveolar duct area (26). Lung endothelial
cells can be found in the capillary wall. These cells build a capillary barrier which
limits the influx of fluid, solutes and macromolecules to the interstitial and alveolar
compartments and keeps the compartments dry to optimize the gas diffusion(27).
Alveolar macrophages (dust cells), float in the lipid layer covering the inside of the
alveolus and are the most numerous cell type in the alveolar space (28). They arise
from monocyte, escape from the blood capillaries and enters through the Kohn
pores into the alveolar space (28). They provide the first line of defense against
inhaled pathogens by ingesting bacteria and particles. Table 1.2 summarizes the
cell population of alveoli and their properties and primary functions.
1.2.3. Mechanical stimuli
The lung is an air pressure supported structure which requires distending
stress to maintain its state of inflation (29). But in general, every time we breathe
in, muscles on our ribs contract, which elevates the chest cavity and lowers the
diaphragm. The two actions assist to expand the thoracic cavity area, which drops
the internal pressure down. Then air from outside travels through the mouth, nose,
nose cavity, pharynx, larynx, trachea, bronchi, and bronchioles to fill up the alveoli.
The ribs return to their original position by contraction of the same group of muscles
and is raised by the diaphragm by the action of the abdominal muscles. This
movements reduces the area in the thoracic cavity and increases the pressure.
The pressure changes in lung affects the opening and closing of the alveolar ducts
4

and alveoli (30). During these actions, human alveoli are primarily exposed to
major three types of mechanical stimuli (Figure 1.3) (Table 1.3) (4), such as :
surface tension at ALI, shear stress due to capillary blood flow, mechanical strain
due to breathing. Also, the stiffness of the alveolar basement membrane plays an
important role in cell modeling and alveolar functionality.
Stiffness of the basement membrane
Most of the cells in human body are anchorage dependent which refers to
the need for cells to be adhered to or in contact with another cell layer, extracellular
matrix, or tissue culture substrate for survival (31). When a cell attaches to a
substrate, its cytoskeleton can sense the resistance or stiffness of the substrates
which leads to remodeling of the cytoskeleton and regulation of different adhesion
proteins of the cells (32, 33). Resistance to deformation or substrate stiffness is
defined as Young's elastic modulus, E, and is reported in units of Pascal (Pa; =
newtons/m2). A stiff matrix that has higher Young's elastic modulus intuitively
provides more resistance than a soft matrix. Substrate stiffness has many effects
on cell function. At the most basic level, stiffness can regulate cell growth, viability,
as well as resistance to apoptosis. The alveolar basement membrane has a
stiffness that ranges from 0.44 to 7.5 kPa depending of the region of the alveolar
wall (34).
Surface tension
The apical side of alveoli are exposed to air while the basal side has contact
with the capillary fluid. In the absence of surfactant, the surface tension at the air5

liquid interface in alveoli is approximately 70 mN/m. The ATII cells in the epithelium
secrete surfactant, a complex mixture of lipids and associated proteins which forms
surfactant film. The surfactant film covers the entire epithelium and reduces the
surface tension from 70 mN/m to nearly 0 mN/m (35). The film also stabilizes the
alveolar structure and plays a very important role in preventing pulmonary edema.
In case of high surface tension, the shape and phagocytic activity of alveolar
macrophages in vivo changes, which confers the idea that the surface tension
influences cell shape and function in the alveolus (36).
Cyclic stretch
Due to the cyclic stretch in the alveolus caused by the continuous change
in lung volume associated with breathing; human alveoli undergo approximately 412% linear strain and the surface area increases from 12-37% (37). The linear
strain could reach 15-25% in patients with acute respiratory failure who are
subjected to mechanical ventilation (4). Mechanical stretch plays a very important
role in maintaining ATI and ATII cell ratios in the alveolus. Presence of cyclic
stretch has shown decrease in the number of cells exhibiting ATII-type cell
morphology and an increase in those exhibiting morphological characteristics
typical of ATI cells (36). Similar phenomena have been identified in neonatal alveoli
as well. Also the distribution of alveolar type cells also depends on the stretch as
ATII cells tend to reside linearly along the thick elastic corners, which are less
movable portions of the alveolus (38). Stretch during breathing is also believed to
trigger surfactant release from these cells, which is critical for maintaining normal
lung functions (36).
6

Shear-stress
Due to fluid circulation through airways and vessels; the normal range for
shear stress in the human vascular system ranges from 10 to 70 dynes/ cm 2 in
arteries and 1 to 6 dynes/cm2 in the capillaries. The shear stress also acts upon
alveolar wall during the flow and influences various biochemical functions of
alveolar cells. An in vitro study was performed to investigate the role of the shear
stress on surfactant secretion by alveolar type II cells and the study suggests that
the surfactant secretion increases with increasing shear stress (39).
Now that we have introduced the basic physiology of human alveoli, we will
discuss the basic concept of AOC and will compare and contrast the existing AOC
models.

Alveolus-on-a-chip (AOC)
An AOC is a multi-channel 3D microfluidic cell culture system that mimics
the activities, mechanics and physiological response of a human alveolus. A basic
AOC consists of a cell culture chamber, cell culture substrate, alveolar cells, input
and output ports for media replenishment and cell seeding (Figure 1.4). Depending
on the complexity of the system it can facilitate fluid flow and mechanical stretch
in which case, the system will be connected to a pump to drive the fluid or create
a vacuum to initiate fluid flow or mechanical stretch. It is crucial to select suitable
cell culture substrates to recapitulate the basement membrane of alveolar
epithelial cells. It is also important to have a reliable and reproducible porous
membrane that can facilitate cell support at air-liquid interface. Finally, to obtain
7

the physiologically relevant responses, it is essential to incorporate features in the
design of the microfluidic platform that can be used to introduce different
mechanical stimuli such as cyclic stretch in the system. This section will discuss
the
1.

Materials that are used as cell culture substrate in current AOC

systems and their suitability,
2.

Process of fabricating pores in the membrane and the reproducibility

of the techniques,
3.

Cell type used in the system and finally

4.

Nature of different mechanical stimuli has been applied to the cells

in the alveolar systems and their relevance to normal alveoli.

Cell culture substrate
In microphysiological alveolar systems, various polymeric and nonpolymeric cell substrates are being used to mimic the native stiffness and support
cell adhesion. In this section we will evaluates the performance of the cell adhesion
substrates used to recapitulate alveolar level function as comparison to
physiological state.
1.4.1. Polydimethylsiloxane (PDMS)
PDMS is a silicone elastomer that is widely used (40-46) as a cell culture
substrate in AOC and was first adapted by the Whiteside’s group (47). PDMS
substrates are membranes made of silicone elastomer which consist of a base
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resin (pre-polymer) and a curing agent (cross-linker). Base resin and curing agent
can be mixed with different mixing ratios to achieve substrate with various stiffness.
The stiffness of PDMS decreases from 2 MPa at a ratio of 10:1 pre-polymer to
curing agent to 0.05 MPa at a ratio of 50:1. A ratio of more than 55:1 is difficult to
handle, the most used ratio lies between 10:1 and 55:1 (48). Some of the
properties of PDMS that can be advantageous and disadvantageous for using in
an artificial alveolar system are listed in Table 1.4.
1.4.2. Polyethylene terephthalate (PET)
Commercially available porous polyethylene terephthalate (PET) with 0.4
µm pores are another preferable choice of cell culture substrate materials for
researchers in a microphysiological system (43, 49) (50-52). PET is the most
common thermoplastic polymer resin of the polyester family consisting of
polymerized units of the monomer ethylene terephthalate, with repeating
(C10H8O4) units. Commercially available substrates are porous and made through
a track-etching process (53, 54). High-energy particles from radioactive decay
leave a trail of damage as they fly through the polymer, and the damaged material
is later removed by chemical etching to create long and narrow pores (55). PET
membrane can also be available in other pore sizes such as 3 and 8 µm than 0.4
µm (Figure 1.5), but membranes with larger pore sizes haven’t been used in
existing AOC systems. We listed some of the advantages and limitations of using
PET as a cell culture substrate in AOC in Table 1.5.
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Fabrication of microporous membrane
The Alveolar cells reside at the junction of gas and liquid where the basal
surface of the cells is in contact with capillary fluid. The apical surface is exposed
to the inhaled atmospheric air and this microenvironment defined as air-liquid
interface (ALI). To create an air-liquid interface it is crucial to have pores in the cell
culture substrate membrane so that nutrients from the basal side can travel
through the pores on the apical surface and support the epithelial cell growth. From
current literature review, PDMS and PET are the main two cell culture substrates
that are used in engineering of an AOC. The pores in commercially available PET
are fabricated by track etching process, whereas, the pores in flexible PDMS are
constructed using soft-lithography. In this section we will discuss the process of
making pores in flexible PDMS, we will also discuss its reproducibility and compare
the effectivity of this process over other alternatives. A microstructuring lamination
technique was developed to obtain microporous polymeric membranes for organson-a-chip (OOC) system initially described by Dongeun Huh et al (1, 42) .Briefly,
1. Silicon wafer was prepared by deep reactive-ion etching that had a
pattern of 50 µm tall and 10 µm diameter circular posts. The height
and diameter of micropillars define the pore size of the membrane,
2. An uncured PDMS membrane of 10 um thickness was spin coated
on a silanized slab of fully cured PDMS,
3. Then the uncured membrane was placed over microfabricated
posts array,
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4. A glass slide and an iron weight were then placed on the PDMS
slab in order to ensure that the posts pierced the uncured PDMS
film, thereby creating through-holes,
5. PDMS pre-polymer sandwiched in between and cured at 60 °C for
at least 24 hours,
6. After curing, the PDMS slab and film (now containing throughholes) were removed from master silicon wafer carefully.
A schematic of this process can be seen in Figure 1.6 (A) (56). Although,
porous flexible membranes used in AOCs are generally fabricated by utilizing soft
lithography techniques, it can be undesirable as they are very expensive to
manufacture, need special facilities, are time consuming with poor yields and are
material specific. Lateral collapse of relief structures and sagging of recessed
structures were reported for various attempts taken to fabricate porous flexible
basement membranes with this technique (Figure 1.6 B) (57). Other techniques
such as E-beam lithography, ion beam milling, and salt leaching have been
developed to fabricate porous membranes. But none of these techniques are
amenable for large scale production with reproducible high yield rate. The
advantages and disadvantages of using soft lithography to fabricate porous flexible
membranes are listed in Table 1.6.
The laser processing of materials, known as ablation, has proven to be an
invaluable technique for obtaining desired patterns on target materials through a
single-step fabrication process. A femtosecond laser applies ultrashort laser
pulses (<10−15 s) to target materials, which minimizes thermal stress and
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collateral damage, thereby resulting in stable and reproducible patterning (58).
Femtosecond lasers offer unique advantages, such as high-precision material
processing, thereby providing the potential for efficient drilling of micropores with
reduced re-deposition of the ablated materials (59). This thesis will demonstrate
the utilization of a femtosecond laser to achieve micron sized pores with ultrahigh
power intensities and ultrashort irradiation periods in Chapter 4.

Cell type
Recapitulation of an artificial organ requires vigilant selection of a cell
source which can provide specific biological functions (60). The main challenge of
culturing ATI and ATII cells in vitro is maintaining them in a differentiated state.
Existing AOC models are utilizing cells from mainly four sources: cancerous cells,
alveolar cells from animals, cryopreserved primary human cells and cells freshly
isolated from patients. We will discuss these four major sources of cells and their
functionality in the respective AOC devices are summarized in following sections.
1.6.1. Cancerous cell line
The most common cell line used in AOC is A549, an adenocarcinoma
derived human alveolar basal epithelial cell. They have been utilized in AOC to
model alveolar-capillary barriers (61, 62), lung (49, 63, 64), lung tumor models
(65), neonatal lung (66), distal lung (67) model etc. None if these models have
characterized A549 cells for markers that specifically represent ATI or ATII cells.
Although in other studies it has been found that A549 cells can produce surfactant
proteins A, B, and C which represent the primary human AT2 cells (22), and
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another study shows that the Raman spectra of A549 cells reveals its similarity
more to AT1 cells than AT2 cells (68). Other studies indicate that the major problem
with A549 cells is their incapacity of forming functional tight junctions, that is, tight
monolayers of polarized cells (69). Another cancerous cell line used in AOC is NCIH441 which is derived from papillary adenocarcinoma and mostly used to study in
vitro model of alveolar type I cells for their ability to produce comparably higher
tight junction than A549 cells (69). Even though cancerous cell lines do not entirely
recapitulate the native physiology of alveoli they are still an invaluable tool to use
in the development of in vitro AOC system to validate the device performance.
1.6.2. Cryopreserved Primary human cells
Primary human lung cells are isolated from human lung tissue and
cryopreserved for future use. Several attempts have been made to use primary
human alveolar cells to model different aspects of the lung physiology. Human
primary Alveolar type I and type II were utilized in recent studies and initiation of
alveolar epithelium layer with tight junctions was reported. But no characterization
was done to distinguish or to show the presence of ATI and ATII cells in the culture.
Human small airway epithelial cells (HSAECs) has been used to model cellular
level injury in microfluidic airway systems (70). These cells express proteins
(CC10) that represent the non-ciliated secretory epithelial cells. It is hypothesized
that cells isolated from the distal portion of lung may contain alveolar type I and
type II cells which can open a new door to researchers in building true model of in
vitro alveolus. In Chapter 6, we will discuss more about the presence of ATI and
ATII cells in HSAEC population. Even though primary cells recapitulate the native
13

physiology of human lung, the donor variability and limited life span can be difficult
to produce reproducible data for disease and drug studies.
1.6.3. Freshly isolated cells
Cells isolated from human lungs unsuitable for transplantation can also
contribute to engineering a physiologically relevant AOC model (71). The lung
might be injured in the transplantation process or the donor might suffer acute lung
disease which can cause the rejection for the lung to transplant. In that situation
cells obtained from that lung might be disease cells or might cause rapid
breakdown of the cells (72). On the contrary, obtaining healthy fresh lung cells is
a challenge because it requires access to donor, material and waiting for the cells
have the possibility of hindering the experimental progress.
1.6.4. Animal cells
Cells were isolated from murine and was used in some of the AOC models
(40, 73, 74). The cells are easy obtain and possible to isolate fresh cells but the
major disadvantages of using primary lung cells from rats suffer from interspecies
differences and are thus less suitable to simulate the responses of the human
alveolus.

Mechanical stimuli in alveolus
The studies carried out to recapitulate the physiology of the alveolus have
emphasized mostly on the air-liquid interface, cyclic stretch and shear stress
(Figure 1.7). One study reports that cells were subjected to a 5 – 12 % a
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unidirectional mechanical stretch in a microfluidic lung device. The study captures
only small section of alveolus with the reasoning that the alveolus experience
unidirectional stretch at a given point only (42). Later, another study presented the
importance of having both solid and liquid stress to recapitulate the physiology of
an alveolus. The alveolar epithelial cells experience solid mechanical stress when
they are exposed to the cyclic stretching and relaxation whereas, fluid mechanical
stresses occur when the air–liquid meniscus expose the alveolar cells to shearing,
shear gradients, pressure, and pressure gradients. In their work they established
a model of the stresses that occur in surface-tension related-diseases (40). The
model lacked the presence of a true air-liquid interface due to having non-porous
membrane. Continuous perfusion was also absent from the reported model.
Another interesting study was conducted where a three-dimensional mechanical
strain was exerted on the alveolar cell using negative pressure. But this system
also lacked the establishment of an air-liquid interface (75).

Ideal alveolus-on-a-biochip / Next generation alveolus
microphysiological systems
Many studies have been taken place to recreate different aspects of the
alveolar system through microfluidics. Table 1.7 attempts to capture the most
important features generally considered as crucial for AOC systems for toxicity
testing. Limitation remains in choosing the suitable cell culture substrate for cell
culture, developing a reproducible fabrication process to obtain porous membrane,
investigating and identifying primary alveolar cells that represent the main types of
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cells in alveoli and recapitulate the relevant principal mechanical stimuli in the
system. Additions of

the described factors can improve the existing

microphysiological AOC systems.
1.8.1. Cell culture substrate: Polyurethane (PU)
Replacing the existing cell culture substrate with PU, a biocompatible
polymeric membrane that does not absorb small molecule, that has the similar
stiffness as alveolar basement membrane and which can be amenable to cyclic
stretch for long term studies can improve the AOC system by eliminating the
chance of drug and toxic screening failure, durability for long term experiment with
physiological breathing condition and the stiffness will facilitate cell growth in
microenvironment close to the in vivo conditions.
1.8.2. Pore fabrication technique: Direct ablation by Femtosecond laser
The use of femtosecond laser can help improve the reproducibility issue
that occurs with soft-lithography. It is possible to fabricate number of porous
samples in matter of hours which can be advantageous where in soft-lithography
it can take days. The reproducible production of porous membrane can encourage
other researchers to use the platform for different studies that needs co-culturing
of cells.
1.8.3. Mechanical stimuli
Combining the physiologically relevant strain at air-liquid interface with
continuous perfusion will truly mimic the principal mechanical stimuli in alveolus.
Addition of these three factors can provide alveolar cells cue to response like in
16

vivo and it will also be advantageous to screen drug and toxic considering these
three stimuli.
This thesis will explore possibility in these areas that has described.
Integration of the desired properties into an AOC system which will give more
realistic model for effective drug screening.
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Figure 1.1 Different layers of an alveolus.
A thin surfactant layer covers the top surface. Alveolar epithelial cells makes
a thin cell layer that almost diffuse to the extracellular basement layer. Interstitial
layer lies between the epithelial basement membrane and capillary basement
membrane. Squamous endothelial cells reside on the capillary wall.
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Figure 1.2 Alveolar cell population.
Alveolar type I and II cells reside on the inside surface of the
alveolus. Alveolar macrophage can be found in the thin layer of surfactant.
Interstitial space is populated with fibroblasts, smooth muscle cells,
myoblasts, pericytes and interstitial cells. Endothelial cells can be found in
the capillaries surround the alveoli.
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Figure 1.3 Different mechanical stimuli in alveolar region.
Figure was adapted from (4). The alveolar epithelium is subjected to surface
tension created at air-liquid interface. They also experience 7-12 % strain during cyclic
stretch due to breathing. The capillaries that surround the alveolus continuously transport
blood and create shear stress on the endothelial cells.
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Figure 1.4 A simple microfluidic device for cell culture.
The device consists of a cell culture substrate, cell
culture chamber, and media chamber and input and output
node for introducing media or flow.
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Figure 1.5 Commercially available porous PET membranes imaged by Keyence digital
laser microscopy.
A) 0.4 µm PET, B) 3 µm PET and C) 8 µm PET. Irregular pore pattern, pore
overlapping and pores with larger defined can be observed. All scale bars are 100 μm.
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Figure 1.6 Fabrication of microporous membrane.
A) Microstructure lamination process to create micron size pores in PDMS. 1)
Uncured silanized PDMS slab is used as substrate, 2) 10 μm thick PDMS was spin coated
on the slab, 3) PDMS attached on the slab was placed on a premade silicon master mold
that has 50 μm tall and 10 μm diameter micropost, 4) The slab compressed on the mold,
5) A custom cut iron weight put on the slab so the post pierce through the uncured PDMS
for at least 24 hours and 6) The porous PU cured at 60 for overnight and carefully peel
off from the slab, B) One of the limitation of the technique : tear in the membrane during
release. Image A adapted from (1), image B adapted from (5).

23

Figure 1.7. Mechanical stimuli in existing Alveolar-on-a-chip models.
A) Combination of air-liquid interface, fluid flow and continuous cyclic
stretch produce by vacuum channels, B) cyclic stretch at submerged condition,
and C) cyclic stretch at submerged condition. Images were adapted from (1-3).
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Table 1.1 Human alveolus structural parameters.

Description

Value

Reference

Average number of alveoli in adult
human

4.8 X 106

(76)

Total numbers of cells in alveoli

230 x 109

(26)

Average alveolar surface area

143 m2

(77)

Alveolar shape

Polyhedron

(78)

Alveolar duct radius

136 µm

(79)

Surface lining complex thickness

50 Aº

(80)

Ratio of gas to fluid in alveolar space

900:1

(81)

Air-blood tissue barrier thickness

2.2 µm

(79)

Barrier between epithelium and
endothelium thickness

0.2 – 0.4 µm

(79)

Diameter of pulmonary capillaries

7.48+2.31 μm

(40)

Epithelium thickness

0.61 µm

(79)

Endothelium thickness

1.24 µm

(79)

Interstitial space

0.42 µm

(79)

25

Table 1.2 Human alveolar cell type and functions.
Description

Morphology

Total
Functions
alveolar
cells,%

Reference

Alveolar type
I cells

Squamous, cover 93% of
the alveolar surface area,
approximately 40
cells/alveolus, diameter
40 µm, volume 1764 µm3

8%

Gas exchange,
fluid transport

(82, 83)

Cuboidal, Generally
covers 5-7 % of alveolar
surface, 60 cells/alveolus,
diameter 8 – 10 µm,
volume 889 µm3

16%

Repair the
alveolar
epithelium when
ATI cells are
injured and
secrete
pulmonary
surfactant
Unknown

(79, 83)

Modulate the
connective tissue
matrix, affect the
alveolar structure
and function
Capillary barrier

(26, 83)

Alveolar type
II cells

Alveolar Type Rare find
III or brush
cells
Mesenchymal Fibroblast, Interstitial
cells
cells, Myofibroblast,
Pericyte, Smooth muscle
cells

37%

Lung
endothelial
cells

Elongated, angular
shape, 632 µm3

30%

Alveolar
Macrophages
or Dust cells

Flat, Diameter 10 – 21 µm 9%
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(84)

(83)

Phagocytic
(83)
defense against
microbial invasion

Table 1.3. Characteristic levels of stress or force in lung structures.
Force
Stiffness of basement membrane
Equilibrium surface tension at ALI
Transpulmonary pressure
Calculated linear strain
Change in surface area
Shear stress at vessel wall
Capillary fluid flow in lower lung

Calculated value
0.44 to 7.5 kPa
25 dynes cm−1
0 – 30 cm H2O (0–3000 Pa)
4 – 12 %
12 – 37%
∼1 -30 Pa
77.4 µL/min
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Table 1.4. The advantages and limitations of using PDMS in an alveolus-ona-chip system.
Advantages
1. Rapid prototyping
2. Cost-effectiveness
3. Transparent, ease with
microscopy
4. Good gas-permeability
5. Excellent adhesion to glass
and many substrates

Disadvantages
1. PDMS is very hydrophobic,
need surface treatment for cell
culture
2. PDMS absorbs some organic
solvents and some hydrophobic
small molecules which can
mislead while screen drugs or
other small agents in the microphysiological system
3. Gas permeability can be also
disadvantageous by means of
inducing bubbles in the system
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Table 1.5. The advantages and limitations of using PET in an alveolus-on-achip system.
Advantages
1. Pore diameter is well controlled
2. Available with different pore
diameters 0.4, 1.0, 3.0, and 8.0
μm which can benefit transport
and permeability studies, cell
co-culture, investigation of
invasion and migration etc.
3. Chemical properties minimize
non-specific binding of
compounds and small
molecules
4. Durable material that will not
break, bend, or curl when
manipulated

Disadvantages
1. Local pore density is not
uniform
2. Overlapping of pores (see
Figure 1.5)
3. Pore density effects the
transparency of the materials;
difficult to image with
membrane that has 3 and 8
micron pores
4. Stiffness doesn’t allow any
mechanical stretch
5. Stiffness is 1 GPa which is 109
times higher than physiological
basement membrane
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Table 1.6. The advantages and limitations of using soft-lithography to
create pores on flexible membranes.
Advantages
1. Pore diameter is well
controlled.
2. It can be carried out
conveniently as the
techniques are well
established in the literature
3. Low in capital cost, easy to
learn, straightforward to
apply, and accessible to a
wide range of users (85)

Disadvantages
1. Not suitable for large scale
production or commercialization
2. As it is difficult to obtain uniform
thickness of the PDMS through spin
coating process, sometimes resulted
in closed pores in the membrane
(86)
3. Regularly, the fragile porous
membrane layer was unable to
remain intact as the layers needs to
be peeled from the posts of the
master wafer, resulting in regions of
porous membrane left behind on the
wafer (86, 87)
4. Time consuming, as the whole
process takes 4 days (1)
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Table 1.7. Current microphysiological systems representing different
aspect of lung.
Publication Model
organ
Viravaidya, Lung,
Sin et al.
liver,
2004 (73)
fat,
other
tissue

Cell culture
substrate
350 µm thick
silicon wafer

Pore
fabrication
No pores

Cell type

Huh,
Fujioka et
al. 2007
(70)

Lung

Polyethylene
terephthalate
(PET)

0.4μm size
pore track
etching

Nalayanda,
Puleo et al.
2007 (61)

Alveol Glass slide
ar
capillar
y

No pores

Primary
human
small
airway
epithelial
cells
(SAECs)
Human lung
adenocarcin
oma cell
line (A549),
Human
Lung
Microvascul
ar Cells
(HLMVE)

Zhang,
Wang et al.
2010 (88)

Lung

0.4μm size
pore Track
etching

Human lung Flow rate of 660
adenocarcin µL /min
oma cell
line
(SPCA1)

10 μm
pores, softlithography

A549 and
HLMVEC

Huh,
Lung
Matthews et
al. 2010
(42)

Cover glass
and
Commercial
membrane
with 0.4μm
size pore
Thin, porous,
flexible
PDMS
membrane
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L2 (rat lung
Type II
epithelial
cells),H4IIE
(rat
hepatocytes
),and
HepG2/C3A
(human
hepatocyte)

Mechanical
stimuli
Flow rate 2
µL/min

Flow rate for
submerged
culture 0.40
µL/min and for
air-liquid
interface 0.25
µL/min
Flow rate of
0.05 μL/min

5% to 15%
unidirectional
mechanical
strain across the
channel length,

Publication Model
organ

Cell culture
substrate

Pore
fabrication

Cell type

Mechanical
stimuli
fluid flow 0.33
μL/min

Nalayanda,
Wang et al.
2010 (43)

Alveolcapillar
y
membr
ane

PDMS molds
with a PET
membrane,
cell culture
cover glass

No pores

A549 and
HLMVEC

Douville,
Zamankhan
et al.
2011(40)

Neonat 100 μm thick
al
PDMS
alveola membrane
r
model
(fluid
filled)

No pores

A549,
primary,
murine
alveolar
epithelial
cells

Tavana,
Zamankhan
et al.
2011(50)

Pulmo
nary
airway
model

PET
membrane of
0.4 μm pore
size

0.4μm size
pore Track
etching

A549

Flow rate of
0.05 μL/min for
submerged and
0.3 μL/min for
ALI culture,
shear stress 15
dyn/cm2
Combined fluid
and solid
mechanical
stresses, 35–
40% cyclic
strain and 3.44
mm/s meniscus
velocity for 288
second
Flow
rate 0.66 μL/min
for submerged
culture and 0.33
μL/hour for ALI

Huh, Leslie
et al. 2012
(89)

Lung

PDMS
membrane

10 μm
pores, softlithography

A549 and
HLMVEC

Flow rate of
~50 µL/min

Xu, Gao et
al. 2013
(45)

Lung/
Lung
Tumor

PDMS
membrane

10 μm
pores, softlithography

SPCA-1,
human lung
fibroblast
cell line
(HFL1),
freshly
isolated
lung tumor
cell from
patients

No mechanical
stimuli

32

Publication Model
organ
Sellgren,
Lung
Butala et al.
2014 (51)

Cell culture
substrate
PET
membranes
with 0.4μm
size pore,
PTFE

Nandkumar, Distal
Ashna et al. lung
2015 (67)

Gelatin vinyl
acetate
scaffold

Stucki,
Stucki et al.
2015 (75)

Lung

PDMS
membrane

Benam,
Villenave et
al. 2016
(90)

Lung/S PET
mall
membranes
Airway with 0.4μm
size pore

Jain, Barrile
et al. 2018
(46)

Alveol
us

7 μm porous
PDMS
membrane

Pore
fabrication
0.4μm size
pore track
etching

3 or 8 μm
pores, softlithography

0.4μm size
pore track
etching

7 μm pores,
softlithography
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Cell type
Primary
airway
epithelial
cells,
fibroblast,
HLMVEC
freshly
isolated
A549,
MRC5(hum
an lung
fibroblast),
alveolar
cells
isolated
from Wistar
rats
Alveolar
epithelial
cells
obtained
from
patients

Primary
human
airway
epithelial
cells
(HAECs),
HLMVEC
Human
Umbilical
Vein
Endothelial
Cells from
pooled
donors,
HLMVEC,
primary
alveolar
epithelial

Mechanical
stimuli
No

Flow rate 33.33
µL/min

3D cyclic
mechanical
strain, 10%
linear strain,
negative
pressure,
stretched for 48
hours
Flow rate 1
μL/min

Flow rate 1
μL/min

Publication Model
organ

Cell culture
substrate

Pore
fabrication

Cell type
cells
containing
type I and II
cells
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Mechanical
stimuli
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Goal and Overview of this Thesis
Microfluidic technologies have enabled many advancements in constructing
of an alveolus-on-a-chip (AOC) that mimics the three-dimensional microphysiology
of the human alveolus. The existing models of AOC is making a great impact
understanding some of the physiology of human alveoli although there are few
shortcomings of these models (1, 2).
1.

Most of these models used either polydimethylsiloxane (PDMS) or

polyethylene terephthalate (PET) membrane as cell culture substrate. PDMS is
known to absorb small molecules which can skew the results during screening
drugs or toxic molecule (3). On the other hand, PET is non-flexible, so it is not
suitable for mechanical stretch.
2.

It is crucial to have a porous membrane as a cell culture substrate to

create an air-liquid interface (ALI). Soft lithography technique has been primarily
used to fabricate pores on PDMS which does not support reproducibility for largescale production.
3.

The mechanical stretch inside an alveolus is a combination of

atmospheric air pressure inside the alveolus and the intrapleural negative
pressure. The cell alignment, location of alveolar epithelial cell types and
differentiation depends on the directionality of this mechanical stretch (4). None of
the existing AOC models truly recapitulate the mechanical stretch as it is in vivo
which can affect the functionality of a normal alveolus.
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This thesis brings a new perspective in the construction of an AOC which
closely mimics the alveolar physiology and discuss the possible applications of this
system for understanding the underlying mechanism of alveolar diseases,
screening drugs and toxic agents for capturing cellular responses.
The major focus of this work is to engineer a physiologically relevant
alveolar-model. In Chapter 1, the basic physiology of human alveoli and its
functionality was discussed. The concept of OOC, its basic components and the
fabrication methods that are relevant to this thesis will be introduced. Finally, the
discussion of the existing AOC models and their advantages and limitations has
taken place.
In Chapter 3, the fabrication of an alternative cell culture substrate
Polyurethane (PU); than PDMS or PET will be reported. The advantages of using
PU over PDMS, the fabrication method, its mechanical properties, and
biocompatible properties will be discussed.
In Chapter 4, the optimized method to fabricate a porous PU membrane
using a femtosecond laser will be presented. The process of optimizing various
laser parameter to create 5-10 µm pore in the PU will be demonstrated. The
validation of the fabricated porous membrane for its capability to permeate small
molecules, support cell culture at ALI and its application as an alveolar-capillary
barrier will be shown.
In Chapter 5, the design and fabrication of a physiologically relevant AOC
will be mentioned. The demonstration of the fabrication method, integration of the
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porous PU membrane in the cell culture chamber, optimization of the fluid flow and
mechanical stretch that are relevant to in vivo will be done. Finally, the utility of the
fabricated device to support alveolar adenocarcinoma cells at ALI and the
exposure of mechanical stretch in a physiological fashion will be reported.
In Chapter 6, the importance of using primary cells for in vitro experimental
model will be discussed. The need of a reliable cell source and selection and
identification of human primary alveolar epithelial cell type I and type II will be
reported. The AOC constructed in this work will be validated by culturing the
primary alveolar epithelial cells with all the mentioned mechanical stimuli. In
Chapter 7, the importance these works, challenges and the future applications will
be mentioned. While individual chapters presented here describe the fabrication
and validation of different components of the AOC systems, taken as a whole, this
dissertation represents a comprehensive approach to engineer an in vitro
microphysiological human alveolar model.
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Abstract
Thin and flexible polymeric membranes play a critical role in tissue
engineering applications for example organs-on-a-chip. These flexible membranes
can enable mechanical stretch of the engineered tissue to mimic organ-specific
biophysical features, such as breathing. In this work, we report the fabrication of
thin (<20 μm), stretchable, and biocompatible polyurethane (PU) membranes. The
membranes were fabricated using spin coating technique on silicon substrates and
were mounted on a frame for ease of device integration and handling. The
membranes were characterized for their optical and elastic properties and
compatibility with cell/tissue culture. It was possible to apply up to 10 kilopascal
(kPa) pressure to perform cyclic stretch on 4 mm-diameter membranes for a period
of 2 weeks at 0.2 hertz (Hz) frequency without mechanical failure.
Adenocarcinomic human alveolar basal epithelial (A549) cells were cultured on the
apical side of the PU membrane. The morphology and viability of the cells were
comparable to those of cells cultured on standard tissue culture plates. Our
experiments suggest that the stretchable PU membrane will be broadly useful for
various tissue engineering applications in vitro.
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Over the last decade, tissue engineering constructs have evolved from
simple planar culture to meticulously engineered platforms such as the organs-ona-chip (OOC) (2). One of the key features that differentiate OOC devices from
conventional tissue-engineered systems is the mechanical stretching of the
substrates to simulate critical biophysical features of an organ (3, 4). This
mechanical stretching has been demonstrated to enhance the recapitulation of
three - dimensional (3D) tissues including cardiac, muscle, vasculature, ligament,
tendon, bone, and lung (5).
Thin and stretchable membranes are utilized to achieve mechanical
stretching in various complex tissue engineering platforms including organs-on-achip. In addition, the membranes should be amenable to sterilization techniques,
biocompatible for cell/tissue culture, gas-permeable to facilitate long term tissue
growth, optically transparent to enable high resolution imaging, and easy to handle
for device integration. Polydimethylsiloxane (PDMS) meets many of these
requirements and is therefore frequently used as a cell culture substrate in OOC
systems (6). However, PDMS has been shown to be absorbent of small,
hydrophobic molecules (7, 8). Such absorption can lead to several limitations for
its application in drug development and toxicity analysis. For example, the
absorption of drug molecules can reduce the effective drug concentrations and can
impact time-dependent changes in target molecules during the course of a study
(9). Therefore, this work focuses on identifying alternate substrates suitable for
mechanical stretching.
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Polyurethane (PU) substrates have been investigated as a substitute for
PDMS membranes for use in microfluidics and tissue culture applications (6). PU
has a number of inherent qualities that are advantageous for cell culture, such as
its elasticity, optical transparency, biocompatibility, and partial permeability to
gases (10, 11). For these reasons, Ingber et al. developed various microfluidic
systems using polyurethane and demonstrated its’ efficacy as a cell culture surface
(12). Their work lays the foundation for using PU substrates to fabricate complex
3D tissue engineering platforms. However, systematic development and
characterization of ‘thin and flexible’ PU membranes is needed to implement
important features such as mechanical and cyclic stretching. There are several
commercially available thin, polymeric membranes that are used in medical
applications (13), such as wound healing patches (14), balloon angioplasty (15),
and culture-plate sealing membranes (16). However, these membranes are not
intended for OOC applications.
In this report, we present the fabrication and characterization of thin and
flexible membranes from castable polyurethane polymer suitable for the OOC
application. First, we describe the method for fabricating the thin membranes and
a handling technique for integrating them into an OOC platform. Second, we
characterize the thickness, flexibility, optical properties, and hydrophobic qualities
of the membranes. Finally, we demonstrate the ability of the polyurethane
membrane-integrated devices to serve as effective cell and tissue culture
platforms.
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Experimental Materials & Methods
Two-part polyurethane systems were obtained from GS Polymers, Inc.
(GSP 1552-2). Silicon wafers were obtained from University Wafer (cat. #452).
Adenocarcinomic A549 cells were obtained from ATCC (ATCC, cat. #CCL185).
Greiner CELLSTAR Bio-One 24-well culture plates (#662160) were used for cell
culture. Additional supplies used include: F-12K media (ATCC cat. #30-2004);
Fetal Bovine serum (FBS) (Thermo Scientific Hyclone, cat. # 10437-028); 0.25%
trypsin EDTA (1x) (Gibco, cat. #25200-056); Live/Dead Viability/Cytotoxicity kit for
mammalian cells (Molecular Probes, cat. #L3224); Dulbecco’s Phosphate Buffered
Saline (DPBS) (Gibco by Life Technologies, cat. #14190-144).

Fabrication of PU membranes
The two polyurethane components were mixed together at a 1:1 weight ratio
using the mixer provided by the company. Approximately 5 grams of the polymer
mixtures were then poured onto a non-treated 100 mm diameter silicon wafer.
Immediately after pouring the polymer, it was spin coated at 500 revolutions per
minute (rpm) for 60 seconds, followed by a range from 500 to 6000 rpm for an
additional 30 seconds. The coated silicon wafer was then cured at atmospheric
pressure and room temperature overnight, followed by thermal treatment at 80°C
for 4 hours. With a sharp knife, the membrane was scored in one cm squares, and
the wafer was submerged in water for 24-48 hours. After soaking, membranes
were ready to be peeled off of the silicon wafer.
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Handling of thin PU membranes
To facilitate release and avoid tearing, tweezers were used carefully to peel
the pre-scored membrane (~1x1 cm) from the wafer. After removing the membrane
from the wafer, we laid the membrane on a flat, glass slide and used microfiber
swabs to smooth out any wrinkles. The membranes were then transferred onto a
laser-cut polyethylene terephthalate (PET) frame. The PET frames were
previously laminated with silicone-based adhesive transfer tape (17) on both sides,
which serves to bond the membrane to the frame. Once the membrane was
transferred onto the frame, a second frame was attached from the opposite side
(see supplementary Video 1 (A-D)). Sandwiching the membrane between the
adhesive PET frames in this way keeps the membrane flat, taut, and easy to
handle for post processing/characterization.

Membrane characterization
3.5.1. Thickness
After the membranes were integrated into the frame, the membranes
became significantly easier to handle for follow-up characterization. The frame and
the membranes were then cut using scissors such that the cross-section of the
membrane was exposed, and its thickness could be measured under a
microscope. For more precise thickness characterization, scanning electron
microscopy (FEI, Inspect F SEM) was utilized. Imaging was performed with the
scanning electron microscope (SEM) in secondary electron (SE) mode, at 15 KeV.
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3.5.2. Optical Characteristics
Gaertner’s L125B single wavelength ellipsometer was used to measure the
refractive index. The instrument was calibrated by measuring the refractive index
of aluminum. Then, three different samples of PU were measured with the same
setting and with a wavelength of 633 nm.
3.5.3. Contact angle Measurement
PU membranes were treated with air plasma cleaner for several treatment
times and stored in phosphate buffer saline (PBS). To investigate the hydrophilic
characteristics the water contact angle of the membrane was measured following
the half-angle method utilizing the CAM-PLUS Contact Angle Meter from
ChemInstruments (18).
3.5.4. Characterization of the elastic deformation behavior of the membrane
by bulge test
The elastic behavior properties of the thin membrane were determined by a
bulge test, described in detail by Huang et al. 2007(19). To perform the bulge test
individual membranes were mounted on a test unit using a combination of laserbased microfabrication and lamination technique (17). The test unit (Figure 3.4A)
was designed such that a given constant pressure could be applied on the 15 µm
thick membrane placed on a 4 mm diameter opening. Each unit was placed in a
vertical position (Figure 3.4B) so that the bulge can be observed through the
microscope (Stereo microscope, AmScope). Constant pressure was applied using
the functionality of a pneumatic pump (PneuWave, CorSolutions). The bulge height
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was observed and captured by image processing software (uEye, IDS Imaging
Development Systems GmbH). Each image was analyzed manually to measure
the bulge heights (Figure 3.4C) against a ruler imaged with the same
magnification. The value of the stress (σ), the strain (ε) and the Young’s modulus
(Y) of the membrane were determined using the following equations (20):
𝑺𝒕𝒓𝒆𝒔𝒔, 𝝈 =

𝑺𝒕𝒓𝒂𝒊𝒏, 𝝐 =

𝑷𝑹

, where 𝑹 =
𝟐𝑻
𝟐𝒉𝟐
𝟑𝒂𝟐

𝒉
𝟐

+

𝒂𝟐
𝟐𝒉

.................................................................... (3.1)
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𝒉𝟑

𝒉

𝑨𝒑𝒑𝒍𝒊𝒆𝒅 𝒑𝒓𝒆𝒔𝒔𝒖𝒓𝒆, 𝑷 = 𝑪𝟏 𝝈𝟎 𝒕 𝒂𝟐 + 𝑪𝟐 𝒀𝒕 𝒂𝟒 ................................................ (3.3)
Where R is the radius of circular membrane, P is the applied pressure, t is
the thickness of the thin membrane, h is the deformed height at the center of the
deflected membrane, ν = Poisson ratio (0.49 was used for calculation (21)), C1
and C2 are constants, where C1 is 4 and C2 is 2.173 for circular opening (20). The
Young’s modulus (Y) and residual stress (σ0 ) was calculated from the experimental
result by curve fitting using GNU plot (22).
3.5.5. Absorption of small molecules
To conduct an investigation of the small molecular absorption by PU and
PDMS, 6-mm diameter discs mounted on a frame with a 15 µm thickness were
fabricated. The membranes were exposed to 200 µL solutions of 1 µM of
Rhodamine for one hour. The discs were rinsed up to seven times with PBS and
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imaged with a Zeiss microscope at 100x magnification with an excitation
wavelength of 550 nm.

Membrane integration into a microfluidic device
Figure 3.1 (layer model) shows the different layers of the cell culture device.
The configurations for each layer were designed using Solid Edge 2D Drafting ST4
software (Siemens PLM Software). The membrane frames and microfluidic
channels were all cut with a carbon dioxide laser cutter (M-360, Universal Laser
Systems) on PET film (0.25 mm; McMaster-Carr) laminated with adhesive tapes
(9122, 3M Company) on both sides. Our thin PU membranes were fabricated and
transferred to PET frames as described in previous sections. This membraneframe “sandwich” was then integrated into the device.

Cell/tissue culture on PU membrane integrated devices
3.7.1. Membrane preparation for cell culture
The PU membranes secured between frames were rinsed using the
Branson ultrasonic cleaner for 5 minutes to remove any dust particles. They were
then integrated into devices for cell culture that allowed for easy access to the
membrane using a pipette, for applications such as cell seeding and media
changing. Prior to cell culture, membrane-integrated devices were sterilized in a
solution of 5% hydrogen peroxide diluted in PBS along with UV-sterilization for 30
minutes. The membranes were then rinsed in sterile PBS and placed into a sterile
100 mm × 25 mm dish. The rinsed membranes were cleaned using the PDC-00161

HP Air Plasma Cleaner (high power, maximum RF 30 watt) for two minutes, and
submerged under 500 µl of 30 µg/ml rat collagen (Corning collagen I) in PBS at 37
°C for four hours. Any excess collagen was aspirated, and the membranes were
rinsed once more with sterile PBS.
3.7.2. Cell culture
Human lung adenocarcinoma epithelial cells A549 (ATCC, Manassas, VA)
were seeded onto the membranes with a density of 1.6 X 105 in a 400µl of F-12K
growth medium supplemented with 10% FBS. The cells were added to the top
compartment of the device. A549 cells with same density were seeded onto 12well polystyrene plates and cultured for five days in F-12k media with 10% FBS as
a control. The growth medium for both culture were changed every other day for a
period of five days. Cells were observed daily using an EVOS microscope (XL
Core).
3.7.3. Cell viability measurements
After 5 days of culture, the membranes were cut from their frames and
transferred onto glass slides. The slides were rinsed three times with PBS and
incubated for 30 min in 2µM calcein AM and 4µM ethidium homodimer-1 using
Molecular Probes’ Live/Dead Viability/Cytotoxicity kit. The cells were then imaged
using the Carl Zeiss Axio Observer Research Microscope. The excitation
wavelength used for calcein was 494 nm and the emission wavelength 514 nm.
The excitation wavelength used for ethidium bromide was 350 nm and the
emission wavelength was 617 nm. The software ZN 292 (1.1.1.0) Carl Zeiss
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microscopy GmbH was used to take the images and they were analyzed using
ImageJ software (National Institutes of Health).

Results & Discussion
3.8.1. Thickness of Polyurethane membranes
Membrane thickness is a function of spinning parameters (rpm and spinning
time) (23). Membranes with various thicknesses were obtained by varying the
spinning speed and their thickness was measured (Figure 3.2A and B). Figure
3.2C shows how the thickness of the PU membrane decreases as a function of
increasing rpm. Membranes thinner than 15 µm were very delicate and difficult to
handle without any damage; as such, we chose to use 15 µm thick membranes for
our study, which were fabricated on the spin coater at 3000 rpm.
3.8.2. Optical Characteristics
Cells and tissues are typically observed through the substrate using highresolution microscopy during typical culture experiments. Therefore, the
substrate’s optical properties, such as its refractive index, are important
parameters to consider when choosing a new material for cell and tissue culture
applications. Table 3.1 shows the refractive index of 15 µm thick PU. The refractive
index of the PU film was close to that of a glass slide (24). Glass is one of the most
commonly used material in microscopy because of its excellent optical clarity. The
similarity in the refractive index of PU and glass indicate that the PU membrane
has a suitable optical clarity for high-resolution microscopy (25, 26).
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3.8.3. Contact angle Measurement
Surface wettability is crucial for typical cell adhesion and growth; it has been
shown that cell adhesion drastically improves on hydrophilic surfaces (27).
Therefore, it is important to be able to manipulate the surface wettability of a new
substrate for cell and tissue culture. We have conducted experiments investigating
the change in hydrophobicity of the PU membrane. As shown in Figure 3.3A the
water contact angle decreases rapidly from 78.66° on untreated PU to 38.4° after
the plasma treatment (within minutes). On further evaluation over several days the
water contact angle remains low for up to 3 days following which we observe some
increase in the hydrophobicity of our membrane (Figure 3.3B). This result is not
unexpected since hydrophobic recovery of PU surface has already been reported
and explained by air contamination, re-orientation of the polar surface groups and
diffusion and reaction of free radicals (28). In contrast, un-modified PDMS has
shown to recover its hydrophobic characteristics (water contact angle 120°) within
100 hours after the plasma treatment (29). Which indicates the use of PU
membrane for applications that need to be perform on less hydrophobic material
than PDMS.
In our study, PU membranes used for cell culture were treated with plasma
for two minutes to facilitate better cell adhesion. The ability to modify the surface
properties of PU using plasma treatment gives the user the flexibility to develop
membranes tailored to their specific applications.
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3.8.4. Characterization of the elastic deformation behavior of the membrane
by bulge test
In order to investigate elastic deformation properties of the membrane we
performed bulge test experiments on 3 different samples. Figure 3.4D shows the
deflection of 15 µm thick PU membranes with various applied pressures. The PU
membranes underwent deformation with pressures up to 10 kPa without tearing.
We calculated that the elastic modulus of the PU membrane was 13.7 megapascal
(MPa). Many OOC platforms such as the lung, the heart, and the gut are subjected
to linear/cyclic stretching of up to 10% (30, 31) to mimic critical biophysical features
of the organ. The PU membranes developed in this work were able to maintain
their integrity while undergoing cyclic stretching at 10% deflection for a period of 2
weeks at 0.2 Hz frequency. Therefore, the PU membranes developed here should
be suitable for long term mechanical stretching in cell and tissue culture
applications.
3.8.5. Qualitative representation of small molecule absorption
The visual comparison of the fluorescent dye absorption of PU and PDMS
are shown in Figure 3.5. As can be seen that Rhodamine B absorbed noticeably
into the PDMS but not into the polyurethane. The qualitative data suggests
drastically lesser absorption of small molecules by PU compared to PDMS.
3.8.6. Handling of thin PU membrane
When released from the substrate, <15 µm thick PU membranes were
susceptible to tearing and crumbling. As a result, they were difficult to handle and
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integrate into microfluidic devices. Consequently, we developed a unique
lamination method which allowed for ease of handling and integration into
multilayer microfluidic devices in a repeatable fashion. Furthermore, it was
possible to transport the membranes between facilities to use equipment for
characterization without destroying the membranes.
3.8.7. Sterilization and Cell viability measurements
For cell and tissue culture, sterilized substrates are necessary to prevent
contamination. PU can be easily sterilized with different techniques such as
plasma cleaning, ultraviolet light treatment, ethylene oxide treatment and hydrogen
peroxide rinsing. However, the fabrication method used in this work involves
different layers of other polymeric substrates such as thin acrylic sheets, which is
not suitable for autoclaving or contact with ethanol. Therefore, we used a
combination of hydrogen peroxide and UV-light exposure to sterilize the PUintegrated platform. To verify the cytocompatibility of PU membrane after
sterilization, A549 cells were seeded on the PU membrane and cultured for 5 days.
Figure 3.6A and B shows A549 cells on tissue culture treated polystyrene plate
and on PU membrane. The number of cells observed on the final day of culture
were comparable to the number of cells on PU substrate, there was no significant
difference in the number of live cells/cm2 between the two substrates (student t
test, p < 0.05). It demonstrates PU membrane’s compatibility as a cell and tissue
culture substrate (Figure 3.6C).
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Conclusions
Here, we have shown how thin, elastic, polyurethane membranes can be
successfully fabricated for the integration into cell and tissue culture devices.
Various properties of our PU membranes, such as their optical clarity, long-term
elasticity, and biocompatibility, further demonstrated the usefulness of these
membranes as a suitable substitute for PDMS. Therefore, we conclude that PU
membrane can serve as a biocompatible and flexible substrate for a range of cell
and tissue culture applications, including the development of complex tissue
engineering platforms such as OOC where mechanical stretching of tissue culture
is often required.
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Figure 3.1 Schematic representation of different layers of the cell culture device.
Parts of Polyethylene Terephthalate (PET) and Acrylic materials were cut
with a CO2 laser and stacked on top of each other with the aid of adhesive layers
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and lamination technique. Fabricated PU was integrated in the device which allows
for cell culture and easy access to the membrane using a pipette.
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Figure 3.2 Fabrication of Polyurethane (PU) membranes.
Immediately after mixing PU components, the mixture was spin coated on
silicon (substrate) at different angular speed for 90 seconds. As the angular
velocity increases, the membrane thickness decreases. Membranes were imaged
by SEM and thicknesses were measured by ImageJ software. Five measurements
for each membrane were taken. (A) And (B) are the SEM images of cross sectional
PU fabricated using 500 rpm for 90 seconds and 6000 rpm for 90 seconds
respectively; (C) Graph showing dependence of PU membrane thicknesses as a
function of spin coating speed.
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Figure 3.3. Hydrophilic and hydrophobic recovery of Polyurethane (PU).
(A) Duration of plasma treatment: PU membranes were treated with air
plasma cleaner for three different treatment times (minutes) and water contact
angles were measured by using Contact Angle Meter (n=3); (B) Hydrophobic
recovery after plasma treatment: PU membranes were stored in PBS after
treating them with air plasma for 2 minutes. Water contact angles were measured
on the day of the treatment (Day 0), Day 3 and Day 7 (n=3).
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Figure 3.4. Mechanical properties of Polyurethane (PU).
(A) Schematic showing the different layers that were assembled to obtain
the bulge test unit; (B) Photograph showing the bulge test unit placed on the
microscope stage: the unit is placed such that it is possible to observe bulging with
high precision through the microscope; (C) Deflected membrane at 10.335 kPa as
observed under the microscope. These images were used to calculate the bulge
height for a given pressure; (D) Graph showing the effect of applied pressure on
the bulge height of the membrane from the centre (n=3); (E) The stress-strain
curve was calculated from the bulge test.
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Figure 3.5. Small molecule absorption into Polyurethane (PU) and
Polydimethylsiloxane PDMS.
Discs of PU and PDMS membranes were immersed in Rhodamine B dye
solutions for 1 hour, rinsed with phosphate buffer saline, and air-dried. (A)
Rhodamine absorption into PDMS; (B) Rhodamine absorption into PU. The images
are representative of three repeated experiments with exact same conditions.
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Figure 3.6. Cell culture compatibility of polyurethane (PU) membrane.
Live and Dead cell staining of the human adenocarcinomia cells (A549)
after 5 days culture on PU membrane, Red: dead cells; Green: live cells; (A) Cells
cultured on tissue culture polystyrene (PS) plate; (B) Cells cultured on PU
membrane; The tissue culture polystyrene (PS) plate was served as the control,
scale bar = 100 µm; (C) Cell viability on the PU membrane was verified after 5
days of culture (n=3). Statistical significance was calculated by student t test where
a value of P < 0.05 was considered statistically significant.
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Table 3.1. Refractive indexes of materials measured at 37°C and λ=633 nm.
Substrate
Refractive Index
Reference
Glass Slide

1.41

(24)

Water

1.34

(25)

PDMS
PU

1.51
1.40

(26)
Measured

76

References
1. Arefin, A., Huang, J.H., Platts, D., Hypes, V.D., Harris, J.F., Iyer, R., and
Nath, P. Fabrication of flexible thin polyurethane membrane for tissue engineering
applications. Biomed Microdevices 19, 98, 2017.
2. Bhatia, S.N., and Ingber, D.E. Microfluidic organs-on-chips. Nat
Biotechnol 32, 760, 2014.
3. Leung, D.Y., Glagov, S., and Mathews, M.B. Cyclic stretching stimulates
synthesis of matrix components by arterial smooth muscle cells in vitro. Science
(New York, NY) 191, 475, 1976.
4. Riehl, B.D., Park, J.H., Kwon, I.K., and Lim, J.Y. Mechanical stretching
for tissue engineering: two-dimensional and three-dimensional constructs. Tissue
engineering Part B, Reviews 18, 288, 2012.
5. Esch, E.W., Bahinski, A., and Huh, D. Organs-on-chips at the frontiers of
drug discovery. Nat Rev Drug Discov 14, 248, 2015.
6. Huh, D., Matthews, B.D., Mammoto, A., Montoya-Zavala, M., Hsin, H.Y.,
and Ingber, D.E. Reconstituting organ-level lung functions on a chip. Science 328,
1662, 2010.
7. Wang, J.D., Douville, N.J., Takayama, S., and ElSayed, M. Quantitative
analysis of molecular absorption into PDMS microfluidic channels. Annals of
biomedical engineering 40, 1862, 2012.

77

8. Mukhopadhyay, R. When PDMS isn't the best. What are its weaknesses,
and which other polymers can researchers add to their toolboxes? Analytical
chemistry 79, 3248, 2007.
9. Regehr, K.J., Domenech, M., Koepsel, J.T., Carver, K.C., Ellison-Zelski,
S.J., Murphy, W.L., Schuler, L.A., Alarid, E.T., and Beebe, D.J. Biological
implications of polydimethylsiloxane-based microfluidic cell culture. Lab Chip 9,
2132, 2009.
10. Gu, P., Nishida, T., and Fan, Z.H. The use of polyurethane as an
elastomer in thermoplastic microfluidic devices and the study of its creep
properties. Electrophoresis 35, 289, 2014.
11. Matsunaga, K., Sato, K., Tajima, M., and Yoshida, Y. Gas permeability
of thermoplastic polyurethane elastomers. Polymer Journal 37, 413, 2005.
12. Domansky, K., Leslie, D.C., McKinney, J., Fraser, J.P., Sliz, J.D.,
Hamkins-Indik, T., Hamilton, G.A., Bahinski, A., and Ingber, D.E. Clear castable
polyurethane elastomer for fabrication of microfluidic devices. Lab Chip 13, 3956,
2013.
13. Zdrahala, R.J., and Zdrahala, I.J. Biomedical applications of
polyurethanes: a review of past promises, present realities, and a vibrant future. J
Biomater Appl 14, 67, 1999.
14. Smiths&Nephew. Allevyn Hydrocellular Foam Dressing. 2016.

78

15. Mishra, S., and Bahl, V.K. Coronary hardware part 3--balloon
angioplasty catheters. Indian Heart J 62, 335, 2010.
16. Aldrich, S. Breathe Easy sealing membrane. 2016.
17. Nath, P., Fung, D., Kunde, Y.A., Zeytun, A., Branch, B., and Goddard,
G. Rapid prototyping of robust and versatile microfluidic components using
adhesive transfer tapes. Lab Chip 10, 2286, 2010.
18. ChemInstruments. CAM-PLUS Contact Angle Meter. 2016.
19. Huang, C.K., Lou, W.M., Tsai, C.J., Tung-Chuan, W.B., and Lin, H.Y.
Mechanical properties of polymer thin film measured by the bulge test. Thin Solid
Films 515, 7222, 2007.
20. Huang, A.W., Lu, C.H., Wu, S.C., Chen, T.C., Vinci, R.P., Brown, W.L.,
andLin, M.T. Viscoelastic mechanical properties measurement of thin Al and AlMg films using bulge testing. Thin Solid Films 618, 2, 2016.
21. Roussel, M., Malhaire, C., Deman, A.L., Chateaux, J.F., Petit, L.,
Seveyrat, L., Galineau, J., Guiffard, B., Seguineau, C., Desmarres, J.M., and
Martegoutte, J. Electromechanical study of polyurethane films with carbon black
nanoparticles

for

MEMS

actuators.

Journal

of

Micromechanics

and

Microengineering 24, 055011, 2014.
22. Kelley, T.W.A.C. Gnuplot 4.4: an interactive plotting program. 2010.
23. Zhao, Y., and Marshall, J.S. Spin coating of a colloidal suspension.
Physics of Fluids 20, 15, 2008.
79

24. Corning. Properties of Code 7800 Pharmaceutical glass. 2016.
25. Daimon, M., and Masumura, A. Measurement of the refractive index of
distilled water from the near-infrared region to the ultraviolet region. Applied optics
46, 3811, 2007.
26. Azmayesh-Fard, S.M., Lam, L., Melnyk, A., and DeCorby, R.G. Design
and fabrication of a planar PDMS transmission grating microspectrometer. Optics
express 21, 11889, 2013.
27. Dowling, D.P., Miller, I.S., Ardhaoui, M., andGallagher, W.M. Effect of
surface wettability and topography on the adhesion of osteosarcoma cells on
plasma-modified polystyrene. J Biomater Appl 26, 327, 2011.
28. Alves, P., Cardoso, R., Correia, T.R., Antunes, B.P., Correia, I.J.,
andFerreira, P. Surface modification of polyurethane films by plasma and
ultraviolet light to improve haemocompatibility for artificial heart valves. Colloids
Surf B Biointerfaces 113, 25, 2014.
29. Bodas, D., and Khan-Malek, C. Hydrophilization and hydrophobic
recovery of PDMS by oxygen plasma and chemical treatment-An SEM
investigation. Sensors and Actuators B: Chemical 123, 368, 2007.
30. Janmey, P.A., and Miller, R.T. Mechanisms of mechanical signaling in
development and disease. J Cell Sci 124, 9, 2011.
31. Benam, K.H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.J.,
Karalis, K., Kim, H.J., MacQueen, L., Mahmoodian, R., Musah, S., Torisawa, Y.S.,
80

van der Meer, A.D., Villenave, R., Yadid, M., Parker, K.K., and Ingber, D.E.
Engineered in vitro disease models. Annu Rev Pathol 10, 195, 2015.

81

Construction of an Alveolar-Capillary Tissue Barrier
Contributors: Ayesha Arefin1,

2,

Quinn Mcculloch3, Ricardo Martinez3,

4,

Simona Alice Martin2, Rohan Singh5, Omar Mohammad Ishak2, Erin Michelle
Higgins6, Kiersten Elizabeth Haffey7, 9, Jen-Huang Huang8, 9, Srinivas Iyer2, Pulak
Nath9, Rashi Iyer10, and Jennifer F. Harris2

1Nanoscience

and Microsystems Department, University of New Mexico,

Albuquerque, NM, 2Bioscience Division, Los Alamos National Laboratory (LANL),
Los Alamos, NM, 3MPA-CINT: Center for Integrated Nanotechnologies, LANL, Los
Alamos, NM, 4Deceased July 23. 2017, 5C-PCS: Physical Chemistry & Applied
Spectroscopy, LANL, Los Alamos, NM, 6University of Texas at Austin, Austin, TX,
7University

of Wisconsin-Madison, Madison, WI, 8National Tsing Hua University,

Hsinchu, Taiwan,

9Applied

Modern Physics Division, LANL, NM,

10Systems

Analysis and Surveillance Division, LANL, Los Alamos, NM.

Portions of this chapter are from the manuscript “Femtosecond Laser
Micromachining of Flexible Polyurethane Membranes for Tissue Engineering
Applications” by Ayesha Arefin1, 2, Quinn Mcculloch3, Ricardo Martinez3, 4, Simona
Alice Martin2, Rohan Singh5, Omar Mohammad Ishak2, Erin Michelle Higgins6,
Kiersten Elizabeth Haffey7, 9, Jen-Huang Huang8, 9, Srinivas Iyer2, Pulak Nath9,
Rashi Iyer10, and Jennifer F. Harris2 (submitted in ACS Biomaterials Science &
Engineering).
82

83

Abstract
Engineered tissue barrier models offer in vitro alternatives in toxicology and
disease research. Most of these models use cell culture substrate and alter
substrate’s mechanical properties such as stiffness, porosity, topological features
etc. to create in vivo like microenvironment. A porous substrate is required in order
to imitate microenvironments for investigating cell to cell contact, air-liquid interface
(ALI) and cell migration etc. To accurately mimic these microenvironments, one
has to enable cell culture on a porous basement membrane that can approach the
stiffness of physiological basement membranes. While pores in some
biocompatible membranes that have micron range thickness (10 µm) and has a
stiffness less than polystyrene (3 GPa) or polyethylene (PET, 2 GPa), have been
developed, there has been little effort to optimize the process to enable rapid and
reproducible development of pores in these membranes. Here, we investigated the
use of laser irradiation with femtosecond (fs) pulses because the combination of
high-precision and cold-ablation cause minimal damage to polymeric membranes.
We demonstrated that this process enables automated, high throughput and
reproducible fabrication of thin, microporous membranes to simulate the ALI milieu
in deep lung. We show the optimization of laser parameters on a thin polyurethane
(PU) membrane. After defining ablation parameters, we patterned pores with an
average of 5 µm diameter with a spacing of 50 µm between adjacent pores. We
then cultured tissue at ALI for 28 days to demonstrate the membrane’s utility in
constructing a tissue barrier model. These results confirm the utilization of fs laser
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machining as a viable method for creating a porous barrier substrate in tissue
engineering platforms.
Keywords
Femtosecond laser machining, thin polyurethane membrane, Micropore
generation, Air-liquid interface.
Graphical Abstract

Tissue construct at air-liquid interface on top, adapted with permission from
(1). Copyright (2016) American Chemical Society.
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Introduction
The successful recapitulation of in vivo tissue barrier microenvironment
depends on different components of tissue engineering. An important component
is the basement membrane which allows cell adhesion, proliferation and
differentiation. Almost all the tissue barrier types need basement membranes to
be porous in order to maintain tissue layer to layer communications such as tissue
to tissue, tissue to air and tissue to liquid contact (2). The pores allow for
exchanging soluble factors which enables tissue nutrition and paracrine cell-to-cell
communication. It can also allow cell migration across the membrane depending
on the pore size and play a role in tissue formation and elicit immune responses.
Therefore, a porous cell culture substrate is needed to fulfill many of these
important functions in tissue barrier engineering.
Currently, commercially available cell culture inserts in two-chamber
systems are used to simulate barrier functionality. In these systems, different cell
types are grown on two sides of a stiff porous membrane composed of materials
such

as

polyethylene

terephthalate

(PET),

polycarbonate,

and

polytetrafluoroethylene (PTFE) which has a Young's modulus of GPa range (3, 4).
This is not optimal for the development of physiologically relevant tissue barrier
models where the native barrier has a stiffness range from 1 to 180 kPa (5, 6).
More recently, 10 µm porous, flexible polydimethylsiloxane (PDMS)
membranes were used to mimic the functions of the different tissue barriers (2, 7).
These porous flexible membranes are generally fabricated by soft lithography
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techniques (7). These techniques are well established in the literature and can be
very useful for rapid prototyping and small-scale production. But commercialization
of soft lithography is still a challenge as the steps involved are not fully automated
(8). Other techniques such as e-beam lithography, ion beam milling, and salt
leaching have been developed to fabricate porous membranes, but none of these
techniques are amenable to large-scale production with a reproducible high-yield
rate (9). The scopes of employing current techniques in processing microporous
polymers are summarized in Table 4.1.
The laser processing of materials, known as ablation, has proven to be an
invaluable technique for obtaining desired patterns on target materials through a
single-step fabrication process. A femtosecond (fs) laser applies ultrashort laser
pulses (sub-picosecond, 10-15s) to target materials, which minimizes thermal
stress and collateral damage, thereby resulting in stable and reproducible patterns
(10). Fs lasers offer unique advantages, such as high-precision material
processing, providing for the efficient drilling of micropores with reduced redeposition of the ablated materials (11, 12). This technique has been used to
process different polymers and biopolymers utilized in tissue engineering
applications including collagen gel (13), collagen and elastin (14), poly(εcaprolactone)/gelatin nanofiber (15), poly(L-lactide) (16-18), hybrid organicinorganic material SZ2080 (19), soft silk protein hydrogels (20), PDMS (21) and
polyurethane (PU) (22) as tissue scaffolds.
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To approach the stiffness of human tissue we have chosen to work with
polyester polyol-based PU as it has a stiffness that is 1000 times less than
commercially available PET membranes. PU is compatible for cell and tissue
culture, approved by FDA for human use such as heart valves and spinal implants
(23) and has advantages over other polymers in terms of small molecule
absorption (24, 25) and flexibility (25). In our previous work, we demonstrated the
fabrication of a 10 µm thin PU membrane that has a Young’s modulus of 13 MPa
as an alternative basement membrane for organs-on-a-chip (OOC) devices (26).
However, this is the first study demonstrating the production of 5-10 µm complete
pores in PU polymeric membranes with a fs laser to be employed in tissue
engineering. To successfully fabricate porous polymeric PU membranes, it is vital
to determine the right combination of laser ablation parameters to obtain the
desired shape and penetration depth. To achieve this, determining the appropriate
settings of laser fluence, overlapping pulse number, and pulse repetition rate, as
well as the substrate that is used to fabricate samples are needs to be determined.
This work demonstrates the strategic and stepwise method employed to determine
these critical parameters. We optimized the laser parameters to obtain pores and
characterized the properties of the pores. Next, we optimized the pore density
according to the physiological relevance (supporting information Figure 8.5) to
ensure molecular transfer from the basal side of the membrane to the apical side.
We cultured human adenocarcinoma cells (A549) on the soft porous membrane
and investigated biocompatibility to demonstrate the utility of this membrane to
support cell and tissue growth. To simulate the tissue barrier in deep lung; alveolar88

capillary barrier, we co-cultured A549 cells at the air-liquid interface (ALI) on the
apical side of the membrane and human lung primary microvascular endothelial
cells (HLMVECs) on the basal side of the membrane and observed cell viability for
4 weeks. Finally, we assessed the barrier function of this model by verifying the
presence of tight junctions and the development of Transepithelial Electrical
Resistance (TEER) (27). Our optimized technique to fabricate porous PU
membranes holds promise to benefit the field of OOC by providing microporous
flexible cell culture substrates in a simple, automatable, reproducible manner.

Experimental methods
4.3.1. Fabrication of porous PU Membrane
PU Membrane Fabrication
Polyester polyol-based PU membranes were fabricated essentially using
the method described in our previous work (24). Briefly, two PU components (GS
Polymers, Inc., CA, USA) with customized viscosity 11,000 cps were mixed
together at a 1:1 weight ratio and the mixtures were then poured onto the wafer on
100 mm diameter non-treated silicon (University Wafer, MA, USA) and quartz
wafer (Coresix Precision Glass, Inc., VA, USA). Immediately after pouring, the
polymer was spin coated (Specialty Coating Systems, Inc., IN, USA) at 500
revolutions per minute (rpm) for 60 s, followed by 1000 rpm for 60 s and 2000 rpm
for 90 s. The coated wafer was then cured by thermal treatment at 83°C for 4
hours.
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Femtosecond laser system
A custom-built fs laser direct-write system was utilized to obtain pores on
the membranes. The system was designed and constructed at The Center for
Integrated Nanotechnologies (CINT), Los Alamos National Laboratory. The
sample was irradiated with laser pulses at a wavelength of 776 nm. These pulses
were achieved by frequency doubling linearly polarized, 800 fs pulses at 1552 nm
obtained from a Raydiance Smart Light laser system. Variable attenuation was
achieved using a polarizing beam splitting cube and a half-wave plate in a rotation
mount. The final focusing optic is a 20× Plan Apo Infinity Corrected Objective from
Mitutoyo, Japan. The PU membranes were loaded on motorized stages with a
synchronized trigger system control by a computer (Transistor-Transistor Logic
(TTL) output from the Newport XPS motion controller). Motion control was
achieved using motorized stages from Newport Corporation. Membranes were
irradiated with the laser using a constant repetition rate of 100 kHz, a fixed laser
energy of 25 µJ and with a linear motion of the stages with 4 mm/s velocity. The
number of overlapping pulses was adjusted by operating the laser in a burst mode
at the aforementioned repetition rate. The parameters used in the experiments are
summarized in Table 4.2.
Handling of thin porous PU membranes
For easy handling of the porous membrane, a PET (0.25 mm; McMasterCarr, IL, USA) frame with adhesive (3M Company, cat. number 91022) on one side
was designed with the aid of Solid Edge 2D Drafting ST10 software (Siemens PLM
Software, TX, USA) and was cut out with a carbon dioxide laser cutter (Universal
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Laser Systems, Inc., AZ, USA). The porous membrane was then transferred to the
PET frame through lamination. A sharp knife was used to lightly score around the
frame. The wafer along with the frame was then submerged in water overnight.
The porous membrane attached to the PET frame was then slowly peeled off and
released from the wafer (Figure 4.1). The frames were then rinsed using a
sonicator (Kendal, NY, USA) for five minutes to remove any dust particles. The
cleaned frames holding porous PU were then utilized for characterization studies.
Characterization of pore sizes
Membrane pore size was measured using scanning electron microscopy
(SEM) FEI Quanta 400F (Thermo Fisher Scientific. MA, USA). Each frame
containing porous PU was cut in half and was mounted onto standard SEM stubs
(Ted Pella Inc., CA, USA) using carbon conductive tabs 12 mm OD (Ted Pella Inc.,
CA, USA) for ease of imaging the basal and apical side of the membrane.
Membranes were sputter-coated with a thin layer of gold (20 nm) using a sputtering
coater (Gatan Inc., CA, USA). Images were captured at various magnifications
using a scanning electron microscope. ImageJ (National Institute of Health, MD,
USA) was used to quantify pore diameters from the SEM images.
Molecule transport across the porous PU
Fluorescein sodium salt (Sigma-Aldrich, MO, USA) was used as a marker
molecule to evaluate the molecular transport across porous PU. The PET
membrane in a commercially available Transwell cell culture insert (Corning Inc.,
NY, USA) was modified by replacing it with the PU porous membrane. The
91

commercial membrane was removed, and the porous PU membranes were
bonded onto the inserts using a UV-curable glue (Dymax, CT, USA), Digital
Syringe Dispenser (Dymax, CT, USA), Medical Device Adhesive (Dymax, CT,
USA). The porous membranes now integrated into cell-culture inserts were then
placed back in the 24-well cell culture chamber plate. To identify molecular
transport capabilities, the bottom chambers of the modified cell culture inserts and
Transwell PET controls (pore diameters of 0.4, 3 and 8 µm) were filled with 100
µM fluorescein solution made with Dulbecco's phosphate buffered saline (DPBS)
(Thermo Fisher Scientific. MA, USA). DPBS solution without fluorescein was
added on the top compartment of the cell culture inserts. The solution from the top
was collected after 24 hours. The collected solution was transferred to a 96 well
plate and the presence of fluorescein molecules was measured by a fluorescence
microplate reader at 485 excitation/528 emission (BioTek Instruments, Inc., VT,
USA). A standard curve was obtained using a serial dilution of the fluorescein
molecule ranging from 0.25 µM to 100 µM. The concentration was interpolated
from the standard curve (n=3).
4.3.2. Engineering tissue at air-liquid interface
Membrane preparation for cell culture
Prior to cell culture, modified cell culture inserts containing the porous PU
and Transwell controls were sterilized in a solution of 5% hydrogen peroxide
(Sigma-Aldrich, MO, USA) diluted in DPBS for 30 minutes. These washes were
followed by UV-sterilization (280 nm) in a UV-Stratalinker 1800 (Stratagene
California, CA, USA) for 30 minutes. Following sterilization, the modified inserts
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and Transwell control inserts were plasma treated (Harrick Plasma, NY, USA) at
high settings for two minutes then submerged under 200 µL of 50 µg/mL rat
collagen (Corning Inc., NY, USA) diluted in DPBS at 37°C for 4 hours. Excess
collagen was aspirated, and all inserts were rinsed once more with sterile DPBS
and stored in a refrigerator until cells were ready to be seeded.
Human alveolar adenocarcinoma cell culture at air-liquid interface
Human alveolar adenocarcinoma (A549) (American Type Culture
Collection, VA, USA) cells were expanded in a T-75 cell culture flask with vent cap
(Corning Inc., NY, USA) to 70% confluency. Cell were obtained at passage 80 from
the company and was used between 3- 5 subculture passages for all the
experiments. Cells were trypsinized with 0.25% Trypsin- EDTA (1X) (Thermo
Fisher Scientific. MA, USA) and were seeded onto the modified cell culture inserts
and Transwell controls with a density of 1.6 X 105 cells/ cm 2 in Ham's F-12K
(Kaighn's) (American Type Culture Collection, VA, USA) growth medium
supplemented with 10% fetal bovine serum (Thermo Fisher Scientific. MA, USA)
and 1% penicillin-streptomycin 10,000 U/mL (Thermo Fisher Scientific. MA, USA).
Cells were added to the top compartment of the modified cell culture inserts and
Transwell controls. Cells were exposed to ALI after they reached 90 percent
confluency at day 2. The growth medium from the bottom compartment was
changed every other day for 28 days and the cultures were observed daily using
a bright field microscope (Thermo Fisher Scientific. MA, USA). Five separate sets
of experiments with three replicates were performed (N = 5, n=15).
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Cell viability assay
Cells grown at ALI were stained for viability. Cell viability was determined
using the two-color fluorescence Live/Dead Viability/Cytotoxicity kit for mammalian
cells (Thermo Fisher Scientific. MA, USA) according to the manufacturer’s
instructions. After staining, cells were observed using fluorescence microscopy at
20X magnification. Ten random fields were selected for each membrane to image
live and dead cells on the porous membrane. The excitation/ emission wavelength
used for calcein was 494/ 514 nm, and for ethidium bromide was 350/ 617 nm.
Co-culture of human alveolar adenocarcinoma and lung
microvascular endothelial cells
To prepare co-cultures, modified cell culture inserts containing porous PU
and Transwell cell culture inserts as controls were coated with collagen on the
apical surface and cell attachment factor (Cell Applications Inc., CA, USA) on the
basal side of the membranes. Human lung microvascular endothelial cells
(HLMVEC) (Cell Applications Inc., CA, USA) were seeded at 1.6 X 10 5 cells/cm2
at the bottom surface of each cell culture insert and allowed to adhere for at least
2 hours. Inserts were flipped and A549 cells were seeded at 1.6 X 105 cells/cm 2
onto the apical surface. Cells were maintained in HLMVEC growth media in the
basolateral chamber and Ham’s/F12K media in the apical chamber. On reaching
90% confluency, media on the apical side was aspirated and cells were cultured
at ALI for 28 days, following which they were stained for the cytoskeleton protein
actin to visualize the cells on both sides of the porous membrane. The HLMVEC
growth medium from the bottom compartment was changed every other day for 28
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days and the cultures were observed daily using a bright field microscope (Thermo
Fisher Scientific. MA, USA). Five separate sets of experiments with three
replicates were performed (N = 5, n=15).
Cell staining for tight junction proteins
Cells grown on both porous PU and commercial Transwell membranes
were stained for the tight junction protein ZO-1. Image-iT Fixation/Permeabilization
Kit (Thermo Fisher Scientific. MA, USA) was used to fix and permeabilize the cells.
ZO-1 monoclonal antibody (1:200) (ZO1-1A12) conjugated with Alexa Fluor 488
(Thermo Fisher Scientific. MA, USA) was prepared in DPBS buffer. The nuclei
counterstaining NucBlue Fixed Cell ReadyProbes reagent (Thermo Fisher
Scientific. MA, USA) was added to the same buffer (1 drop/mL). Fixed cells were
incubated with buffer containing ZO-1 antibody and Nucblue for 24 hours at 4°C in
the refrigerator. The following day, cultures were washed three times with DPBS
and the membranes from the inserts were carefully cut out with a sharp knife. The
membranes were mounted on a glass slide using ProLong Diamond Antifade
Mountant (Thermo Fisher Scientific. MA, USA). The slides were observed using a
fluorescent microscope (Carl Zeiss AG, Zeiss AxioVison 4 microscope), software
ZN 292 (1.1.1.0). The excitation and emission wavelength used for ZO-1 were 495
and 519 nm, and for NucBlue were 360 and 460 nm.
Cell staining for cytoskeleton
Cells grown on porous PU-modified inserts and Transwell controls were
stained for the cytoskeleton protein Actin. Image-iT Fixation/Permeabilization Kit
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(Thermo Fisher Scientific. MA, USA) was used to fix and permeabilize the cells.
ActinGreen 488 ReadyProbes Reagent (Thermo Fisher Scientific. MA, USA) was
prepared in DPBS buffer according to manufacturer’s instructions. The nuclei
counterstaining NucBlue Fixed Cell ReadyProbes reagent (Thermo Fisher
Scientific. MA, USA) was added to the same buffer (1 drop/mL). Fixed cells were
incubated with buffer containing Actin antibody and Nucblue for 24 hours at 4°C in
the refrigerator. The following day, cultures were washed three times with DPBS
and the membranes from the inserts were carefully cut out with a sharp knife. The
membranes were mounted on a glass slide using ProLong Diamond Antifade
Mountant (Thermo Fisher Scientific. MA, USA). The slides were observed using a
fluorescent microscope (Carl Zeiss AG, Germany), software ZN 292 (1.1.1.0). The
excitation and emission wavelength used for ZO-1 were 495 and 519 nm, and for
NucBlue were 360 and 460 nm.
Measurement of TEER
The electrical resistance of epithelial cell layers on porous PU and PET
membranes were measured using a Millicell-ERS volt ohmmeter (Merck Millipore,
MA, USA) equipped with chopstick electrode set for EVOM2, 4mm (World
Precision Instruments, FL, USA) and expressed in Ohm.cm 2. Briefly, porous PU
membranes and Transwell PET membranes with and without cells in the culture
medium were studied over a cultivation period of 28 days. Before the
measurements, the top and bottom chambers of the cell culture inserts were
partially filled with 200 µL and 600 µL growth media, respectively. The cell culture
plates were allowed to equilibrate to room temperature for 15 minutes. Electrodes
96

were placed at the upper and lower chambers of the inserts and resistance
measured with the volt-ohmmeter. Resistance was shown as the mean (resistance
X area) of five independent experiments with three replicates each. Calculations
for TEER are reported by using the following equation 1.
𝑻𝑬𝑬𝑹 (𝜴 × 𝒄𝒎^𝟐 ) = (𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝒗𝒂𝒍𝒖𝒆 (𝜴) −
𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝒗𝒂𝒍𝒖𝒆 𝒐𝒇 𝒕𝒉𝒆 𝒃𝒍𝒂𝒏𝒌 𝒄𝒐𝒏𝒕𝒓𝒐𝒍 (𝒎𝒆𝒎𝒃𝒓𝒂𝒏𝒆 𝒘𝒊𝒕𝒉𝒐𝒖𝒕 𝒄𝒆𝒍𝒍𝒔)(𝜴)) ×
𝑴𝒆𝒎𝒃𝒓𝒂𝒏𝒆 𝒂𝒓𝒆𝒂 (𝟎. 𝟑𝟑 𝒄𝒎𝟐 ) ..................................................................................................... (4.1)

4.3.3. Statistical Analysis
For the characterization of pore properties, the data are presented by the
mean of three independent experiments mean ± standard deviation (SD). To
examine the differences between groups of pores generated with different
overlapping pulses, Student's t-tests (α risk = 0.05) were used. The measurements
of TEER presented as mean ± the standard errors of three independent
experiments. To represent differences between TEER measurements between
groups, statistical analysis was performed using single factor one-way analysis of
variance (ANOVA) with the Tukey HSD post hoc multiple comparison tests with a
probability of P < 0.05 regarded as significant.

Results
4.4.1. Fabrication of porous membrane
Thin PU membranes with 12 ± 3 µm were fabricated utilizing spin coating
technique. The ablation threshold of PU membrane was investigated by inspecting
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the influence of fs laser pulses on crater formation at different laser fluences (1.42
to 23.25 J/cm2). An array of 15 craters was created using overlapping pulses; 35
on and 3750 off at 100 kHz repetition rate and six different previously determined
fluence. The pulse width and laser spot size (Table 4.2) were constant throughout
the experiments. The craters were imaged using SEM and ablation damage
diameter was measured using ImageJ. The ablation threshold of PU was
calculated using diameter-regression technique (28, 29). A scatter plot was
obtained from the experimental data of squared crater diameter and the
corresponding laser fluence using logarithmic values (Figure 4.2A).
The damage threshold can be derived from linear fitting of the data,
determined by the fluence for which linear fit goes down to D2 = 0 (equation 2). In
our current experimental set up, laser beam spot radius was 6 µm. Here, we found
the ablation threshold (Fth) of PU is 1.59 J/cm2.
𝐹

D2 = 2𝜔02 ln (𝐹 ) ........................................................................................................ (4.2)
𝑡ℎ

𝐹𝑡ℎ = 𝑒 −

−11.30⁄
24.365

= 1.59 𝐽/𝑐𝑚2

Where,
D2 = Squared crater diameter
ω0 = laser beam spot radius
F = Laser fluence
Fth = Ablation threshold
After determining the ablation threshold, we investigated the effect of
number of overlapping pulses on pore formation. We initially conducted an
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experiment to find a range of overlapping pulses that create pores and not craters.
Our study shows (Figure 4.2B) a single pulse creates a crater whereas ablation
depth increases with the increasing overlapping pulses, and with a high number of
overlapping pulses (N = 100) we could obtain an average of 12 µm diameter pore.
We then investigated the effect of 10 to 50 overlapping pulses on our PU
membrane. We performed SEM to determine the pore diameter created with
different overlapping pulse numbers. Pore diameter was measured from SEM
micrographs for both top and bottom surfaces. The diameter was plotted against
the number of pulses used to create the pores. The smallest pore diameter can be
formed with 10 overlapping pulses whereas 50 overlapping pulses creates an
average opening of 11.5 µm on top and 6 µm on the bottom (Figure 4.2C).
We further investigated the quantity/percentage of complete pore formation
over the laser treated area. The area treated with less than 35 overlapping pulses
had blind pores or craters. All the completely ablated pores are created by more
than 35 overlapping pulses were complete pores and had hardly any re-deposition
of polymers in the pore (Figure 4.2D).
We performed z-scan technique (13) to determine the effect of focus
position on pore formation and diameter. In this experiment, the laser fluence was
held at a fixed value of 23.35 J/cm2 and fixed overlapping pulses of 35 on and 3750
off, repetition rate 100 kHz. The axial distance (z) between the objective lens and
the target was varied, with negative z corresponding to the focus point lying within
the samples. No complete pores were observed when the laser focus point
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reaches 15 µm above the sample or 9 µm into the sample. In Figure 4.3, our study
also shows that the pore diameter remains around 8 µm (top surface) and 5 µm
bottom surface for the focus distance difference -2 µm to +5 µm range.
Further, we investigated the effect of the substrate upon which PU was
spun, on pore formation. We used SEM to compare the pores drilled on both a
silicon wafer and a quartz wafer utilizing the same laser parameters. Figure 4.4
A,B shows pores drilled on PU membrane that spun on quartz has average 9.4 ±
0.3 µm pore diameter on top surface and 4.9 ± 0.6 µm pore diameter on bottom
surface.
Fs laser-fabricated porous PU membranes were tested for the ability to
allow for molecular transfer (Figure 4.5A). Fluorescein transfer was detected using
a microplate reader after 24 hours to allow for fluorescein transport. The
concentration of the fluorescein molecule reached equilibrium after 24 hours,
demonstrating the potential for nutrient transfer across the porous PU membrane
(Figure 4.5B).
4.4.2. Engineering tissue at air-liquid interface
We employed the porous PU membrane to engineer a cellularized tissue
barrier model. An array of 7 x 7 mm pores with 50 µm spacing between adjacent
pores was created using a fs laser. The porous membranes were glued on the
bottom of commercially available cell culture inserts that had been previously
prepared by taking out the commercial PET membrane. Porous membranes were
sterilized, and surfaces were modified using extracellular matrix. We studied the
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adhesion of (A549) cells on fs-modified PU membranes. Cells were cultured on
conventional porous PET Transwell membranes and on porous PU. After two days
of submerged culture, cells were exposed to the ALI as in the human body. After
28 days of culture, a live and dead staining was done to show the viability of A549
cells on porous PU membranes (Figure 4.5C).
To further validate the potential application of our porous PU membrane in
tissue engineering we demonstrated the co-culture of cells on both sides of the
porous membrane. In our study, we co-cultured A549 cells on the apical and
HLMVECs cells on the basal surface of the membrane (Figure 4.6), respectively.
The tightness of the cell layers was verified by the measure of TEER values
Figure 4.7A shows that the air-lifted A549 cell culture forms TEER of average 46
± 4 Ω.cm2 while the TEER increases to 56 ± 14 Ω.cm 2 in the co-culture of A549
and HLMVECs shown in Figure 4.7B. In addition, immunofluorescence staining
was done to confirm the presence of tight junctions in both epithelial and
endothelial cells Figure 4.7C, D.

Discussion
To mimic the ALI in vitro, one has to fabricate a porous membrane that
closely mimics physiological basement membranes. Various techniques have
been employed to produce micropores in polymeric membranes, yet there is still a
need of a reliable and optimized technique for the robust production of this porous
membrane. In our current study, we have successfully optimized fs laser
parameters to develop micropores in a thin, flexible polymeric membrane. Fs laser
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is a unique tool to micro-machine transparent material because it produces a
minimal heat affected area on the processed material and high precision can be
achieved in terms of geometry (28). The shape of a microstructure produced by a
fs laser depends on the material properties and can be influenced by regulating
the number of overlapping pulses and focus height.
To obtain the optimum fluence to create microstructures on a target area,
we inspected the ablation threshold of PU membrane (30). Materials ablation
threshold can be defined as the minimum optical energy required to remove
material from a unit surface area (31). The rapid pulse energy deposited by a laser
onto the surface of the sample material within 100 fs initiates non-linear absorption.
Ablation occurs when a large number of electrons in the solid being ionized reach
a critical density. We obtained our ablation threshold at a fluence of 1.5 J/cm 2.
From our observation, the target areas were cleanly cut and there was no debris
around the ablated area on PU membranes ablated on quartz wafers (31, 32).
These findings lead us to consider that the high flux of photons delivered by the fs
laser ablated the focused region on the material into plasma. In contrast to our
study, a previous work reported making holes on PU with an excimer laser which
resulted in craters instead of complete pores with excessive heat-affected zones
and poor edge quality (33). A fluence of 23 J/cm 2 was chosen to work with as it
produces a complete pore in the membrane. After determining the ablation
threshold, we varied overlapping pulse numbers to create pores with the smallest
diameter possible. From our observations, the pore diameter and penetration
depth increase with the number of overlapping pulses. For 10, 20 and 30
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overlapping pulses, the percentage of complete pores was less than one hundred
percent and we noticed blind pores or craters. The crater formation can be
explained by reduced ablation ability of the number of overlapping pulses used. As
the pulses penetrate through the material, photons from each pulse begin to ablate
the materials and engage into strong interactions with the induced plasma losing
energy in the process, reducing the ablation efficiency (34). When the number of
overlapping pulses increases, the probability of obtaining complete pores also
increases and, in this case, 35 overlapping pulses was required to obtain complete
penetration on a 10-12 µm thick PU membrane (Figure 4.2B, C, D). Next, we
investigated the effect of focus position with respect to the material surface on pore
diameter. As our membrane thickness is not entirely uniform (variation 1-3 µm), it
is likely that the focus points vary when the laser scans through the samples. In
Figure 4.3, we presented the results obtained by machining pores on PU with
varying focus heights (z axis). Our data show that the pore diameter remains
around 8 µm on the top surface and 5 µm on the bottom surface when the height
of the focus spot varied from -2 to +5 µm. The region of quasi-uniform intensity of
a focused beam lies in the waist of the pulse. When this region lies in the -2 to +5
µm range, it was possible to create pores with similar diameter. Conversely, when
the focus spot moves away from the substrate, the ability to create pores that
penetrate the entire depth of the membrane is reduced. We selected parameters
to create reproducible pores on the membrane even with the 1-3 µm variation in
membrane thickness.
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The investigation of substrate effect on pore formation revealed that the
pores ablated on PU on silicon substrate are comparatively bigger in diameter,
have irregular shapes and damaged edges (Figure 4.4A, B). In contrast, the pores
fabricated on the quartz wafer present sharp edges and smooth side walls, while
the quartz remains undamaged (Figure 4.4A). The damage threshold of these
substrate materials can be a possible explanation for this phenomenon where
silicon has a significantly smaller energy band gap than that of quartz, 1.1 eV as
compared to 9.3 eV, respectively (35, 36). Based on all our optimization
experiments, a set of process parameters were selected with a combination of 35
overlapping pulses on and 750 overlapping pulses off, 100 kHz repetition rate and
23.35 J/cm2 of laser fluence to fabricate porous PU membranes on quartz for
further studies.
The ultimate goal of our work was to create porous membranes that can be
used to culture cells at air-liquid interface. To assess the efficiency of molecular
transfer through the membrane, we showed that fluorescein diffused through
porous PU similarly to commercially available Transwell inserts. The biggest
molecule in the cell culture media we intended to use was albumin; which has a
Stokes radius of 3.39 nm where the radius of fluorescein is 0.45 nm. We further
investigated the capability of the porous membrane to diffuse nutrients through the
fabricated pores by culturing A549 cells on top of the porous membrane and
observing their growth/viability at the air-liquid interface. The live cell layers on
porous PU membrane were comparable to traditional ALI cultures. This
demonstrates that the nutrients can efficiently transfer from the basal side of the
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porous membrane to the cells residing on the apical side of the membrane (Figure
4.5C). These results lead us to co-culture epithelial and endothelial cells on both
side of the membrane to create a three-dimensional tissue barrier construct (Figure
4.6A, B). The constructed tissue barriers were further investigated for their ability
to produce tight junctions. Even though several studies have reported contradictory
results, it has been reported in the literature that A549 cells either do not express
tight junctions (37) or do so at very low concentrations leading to very low TEER
values (7, 27, 38-45).
Interestingly, the TEER values for cells cultured on porous PU were higher
compared to the values obtained from the cells grown on commercial PET
Transwell membranes with 0.4 µm pore diameter. Twenty-eight days post ALI,
TEER value was almost double in epithelial cells cultured only on the apical side
of porous PU than cells cultured on 0.4 µm porous PET shown in Figure 4.7A. At
the same time, the TEER value was approximately one and a half times higher for
cells grown on both sides of porous PU than cells grown on both sides of the
Transwell membrane (Figure 4.7B). Similar phenomena of higher TEER in cells
cultured on porous PU compared to cells cultured on PET were observed when
culturing cells on Transwells with 8 µm pore diameters (supporting information
Figure 8.6, Figure 8.7). As Transwell and PU membranes have different stiffness,
it is possible that the increased TEER might be an outcome from culturing cells on
softer substrates. For example, in one study, lung microvascular endothelial cells
exhibited altered permeability depending on the stiffness of the substrate on which
they were cultured (46). The cells were cultured on substrates with an intermediate
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stiffness (4 MPa), more flexible substrates (0.15 MPa), or abnormally rigid gels (35
MPa). The cells on the intermediately stiff substrate exhibited well-developed cellcell adhesions where the other two conditions resulted in round cell morphology
and disrupted cell-cell junctions. While the effect of substrate stiffness on tightjunction formation is still not fully understood, our study supports that
micromachined PU can be utilized for the development of an artificial alveolar
membrane with tight junctions.

Conclusions
Here, we demonstrate a simplified method for the fabrication of micronsized pores on thin PU membranes with a stiffness of 13 MPa. Fabrication of
micropores by fs laser ablation offers unique advantages in a number of
applications: for examples our approach provides a high-throughput method to
rapidly produce porous membranes. With this method, it takes approximately 5
hours to fabricate and cure 10-12 µm thin PU membrane and 3.5 minutes to
machine approximately 68,000 pores in a 7 x 7 mm square fraction of the
membrane with a spacing of 50 µm between the adjacent pores followed by <24
hours to release it from the wafer for further applications. It is possible to modify
the pattern of the pores, pore density and obtain features down to 2 µm with this
laser system. Various laser parameters including the number of overlapping
pulses, focus height, and pulse energy are optimized in this study. Others can
utilize the methods presented here as a stepwise guide to optimize other polymers.
Fs laser micromachining can more appropriate than soft lithography when the
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application requires large scale production of the porous membrane. The end
product from laser micromachining also has a high yield, almost 100% where softlithography suffers low yield as the process is not fully automated and can cause
technical issues like lateral collapse of relief structures and sagging of recessed
structures and tearing in the porous region during peeling etc. (47, 48).
The fabricated porous membrane was comparable in molecular transfer to
available commercial Transwell systems and able to sustain cell growth at the ALI
for 28 days. Furthermore, we demonstrated the application of the porous PU
membrane in tissue engineering by recapitulation of barrier function. The
demonstrated co-culture of cells on both sides of porous PU offers the potential of
the construction of an in vitro tissue barrier to model alveolar-capillary interface.
The porous membrane provides advantages of culturing multiple types of cells in
tissue-tissue, tissue-air and tissue-liquid microenvironments. The higher electrical
resistance observed when cells were cultured on porous PU shows the formation
of tight junctions and tissue formation, rendering the membrane ideal for other
tissue culture applications requiring a softer, flexible substrate. Further, due to the
ability to change the modulus as a function of membrane thickness, a variety of
cell types can be cultured to form complex physiologically-relevant stretchable
tissue barriers representing different organs, such as skin, vascular structures, and
gut. Coupled with its biocompatible properties, the microporous PU membrane is
an excellent candidate for complex tissue engineering applications required for the
development of human OOC.
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Supporting information
Images describing the basis of selecting pore densities and the comparison
of the barrier functionality with commercially available porous membrane. Figure
8.5 - pore densities at physiological and commercially available system, Figure 8.6
and Figure 8.7- comparison of TEER measurements between 5 µm porous PU
and 3 and 8 µm porous PET membranes.
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Figure 4.1. Schematics of the fabrication process of porous polyurethane (PU)
membrane.
A) Untreated quartz wafer was used as a substrate; B) Two components of
PU were mixed and poured on quartz and a thin PU membrane was spin coated
on top quartz wafer; C) PU membrane was patterned by an array of micropores
using femtosecond laser with optimized parameters; D) PET frame with adhesive
on one side laminated on porous PU; E) PET laminated membrane on the wafer
was submerged under water overnight. A sharp knife was used to score around
the edges of the PET frame and porous PU that is attached to PET frame was
released; F) Porous PU on PET frame attached by a thin layer of adhesive.
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Figure 4.2. Optimization of the laser parameters for creating pores in
polyurethane (PU) membrane.
A) The multi-shot ablation threshold measurements of PU membrane: An array of
craters was patterned on the PU membrane using overlapping pulses of 35 on and
3750 off at repetition rate of 100 kHz. The D2 data are averaged of 10 data points
and laser fluence from 1.42 to 23.35 J/cm2 were used to ablate the craters. The
squared diameter D2 of the ablated areas is plotted as a function of the laser
fluence F (logarithmic values).The slope of the linear fit eq:2 yields the beam radius
at the surface, ω 0 , and the extrapolation to zero provides the multi-shot ablation
threshold of PU at Fth where, overlapping pulses (OP) = 35.B) Pore formation:
scanning electron microscope (SEM) images showing evolution of craters or pores
on PU membrane induced by laser ablation for fluence of 23.35 J/cm2, repetition
rate of 100 kHz for various overlapping pulses (OP). C) Dependence of pore
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diameter (µm) on the number of femtosecond laser overlapping pulses: Laser
fluence and repetition rate used was 23.35 J/cm2 and 100 kHz, respectively. Pore
diameters were measured by SEM and data are presented as mean ± SD from
three independent samples. D) Optimization of overlapping pulse number for
consistent pore production: SEM images for varying overlapping pulses from 10 to
50 with a distance of 25 µm center to center were observed through imageJ plot
profile feature. A line was drawn on the pores visible in the image and by employing
plot profile function two-dimensional graph of the intensities of pixels was obtained.
The x-axis represents the horizontal distance through the selection and the Y-axis
the averaged vertical pixel intensity. The grey value of a pore is average close to
zero where the craters have a higher value.

112

Figure 4.3. Changes in ablation diameter due to varied focus distance.
A toolpath was drawn where the focal point of the laser will move along the
z-axis from positive to the negative direction. Between each subsequent laser
pulse burst, the Z axis moved approximately 3 µm distance. The z-scan was done
on polyurethane (PU) coated on quartz wafer with 35 overlapping pulses on and
3750 overlapping pulses off. The laser fluence used for the scan was 23.35 J/cm 2
and repetition rate 100 kHz. The diameter of top and bottom pores was measured
by scanning electron microscope (SEM). The data is represented by means ±
standard deviation from three different independent samples. The shaded region
represents statistically similar diameter of the top and bottom pores for that range
of Z-axis. Two-tailed, paired student’s t-test was performed to verify any difference
between the adjacent pore diameter of the pores on top and bottom surfaces and
P < 0.05 were regarded as significant.
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Figure 4.4. Effect of substrate on pore formation and diameter.
Polyurethane (PU) membrane was spin coated on both silicon and quartz
wafer. An array of pores was patterned on the membrane using 35 overlapping
pulses on and 750 overlapping pulses off, 23.45 J/cm 2 fluence and repetition rate
100 kHz. (A) Micrograph panel shows pores on the top and bottom surface of PU
that was spun on silicon and quartz wafer. (B) Graph representing pore diameters
on top and bottom surface of PU that was spun on silicon and quartz wafer. The
data were obtained from three separate data analysis. The data represented by
means ± standard deviation from three different independent samples. Two-tailed,
paired student’s t-tests were performed to verify any difference between the pore
diameter of the top surface of PU on silicon and quartz and same for the pore
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diameter on the bottom surface for both substrate, P < 0.05 were regarded as
significant (*).
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Figure 4.5. Cell culture at the air-liquid interface (ALI) using porous
polyurethane (PU) membrane.
(A) Diagram showing the experimental set up to perform molecular
permeability testing of the porous membrane. 100 µM fluorescein solution was
added to the bottom chamber of commercially available Transwell cell culture
inserts and cell culture inserts modified to contain our porous PU membrane.
DPBS solution was added to the top and incubated for 24 hours. The solution from
the top was collected and the presence of fluorescein molecules was measured by
a microplate reader, (B) Graph showing the concentration of fluorescein was
similar across all cell culture inserts after 24 hours of incubation. Student’s t-test
was performed, and no statistical significance was observed in the fluorescein
concentration

between

the

groups,

(C)

Live/Dead

assay

for

human

adenocarcinoma cells (A549) cultured at ALI for 28 days. Cells were seeded on
inserts with PET at three different pore sizes and on inserts with our porous PU
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membrane at the same density. After culturing the cells for 2 days in submerged
conditions, cells were air-lifted (day = 0); (a) 0.4 μm diameter porous PET, (b) 3
μm diameter porous PET, (c) 8 μm diameter porous PET, (d) 5 μm diameter porous
PU; (1) fluorescence images of Calcein AM at 520 nm, (2) fluorescence images of
Ethidium homodimer 1 at 617 nm and (3) merged overlays of the fluorescence
images. Scale bar =100 μm, N=5, n=15.
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Figure 4.6. Alveolar-capillary tissue construct.
(A) Confocal image showing human adenocarcinoma cells (A549) cells on
top and primary human lung primary microvascular endothelial cells (HLMVECs)
on the opposite side of a porous polyurethane (PU) membrane. (B) Schematics of
a tissue construct at air-liquid interface and the constructed cellularized model.
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Figure 4.7. Characterization of the functionality of the constructed tissue
barrier.
Human adenocarcinoma cells (A549) cultured separately and with primary
human lung primary microvascular endothelial cells (HLMVECs) at the air-liquid
interface (ALI) for 28 days. Cells were seeded on only apical or on both apical and
basal side of Transwell PET cell culture inserts with 0.4 µm diameter as a control
and porous PU cell culture inserts at the same density. After culturing the cells for
2 days in media, cells were air-lifted (ALI) (day = 0) and grown for 28 days at ALI,
(A) Transepithelial electrical resistance (TEER) measurement data for cells
cultured only on the apical side of the cell culture inserts, (B) TEER measurement
data for cells cultured on both apical and basal side of the cell culture inserts are
presented, (C) Immunofluorescence images showing the presence of the tight
junction protein ZO - 1 in A549 layer, (D) Phase contrast images showing the
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presence of tight junction protein VE - cadherin in HLMVE cell layer. The
measurements of TEER presented as mean ± the standard errors of three
independent

experiments.

To

represent

differences

between

TEER

measurements between groups, statistical analysis was performed using single
factor one-way analysis of variance (ANOVA) with the Tukey HSD post hoc
multiple comparison tests with a probability of P < 0.05 regarded as significant (*),
N=5, n=15.
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Table 4.1. Comparison of different micromachining techniques to fabricate
thin microporous polymeric membrane.
Techniques

Scope

References

Soft lithography
(microstructuring lamination approach)

Limited for large scale production,
technical issues: lateral collapse of the
mold, sagging, low reproducibility, tearing
and material specific

(91, 92)

E-beam lithography

Time Prohibitive

(91)

Ion beam milling

Production scalability/ ion damage and
high operation costs

(78)

Continuous Wave Laser
micromachining

Material modification by heat effects,
resolution limitations

(91)

Femtosecond laser

High throughput, reduced heat affected
zone, minimal to no collateral damage,
no material limitation

(59, 91, 92)
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Table 4.2. Femtosecond Laser Processing Parameters
Parameters

Definition

Parameter Used

Wavelength (λ)

776 nm

Objective lens

20x

Beam waist (ωp)

Location along the
propagation
direction where the
beam radius has a
minimum

6 µm (measured)

Focus height (z)

Position of the laser
focal point from the
sample

On the surface

Pulse duration (τp)

The duration of an
optical pulse

853 fs

Laser Fluence (F)

Total optical energy
content of a pulse

23.3546 J/cm2

Number of overlapping pulses
per focal spot (OP)

Number of pulses
hitting the same
target spot

35 overlapping
pulses on, 750
overlapping
pulses off

Pulse repetition rate (f)

Number of emitted
pulses per second

100 kHz

Scan rate

Stage velocity to X
and Y directions

4 mm/s
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Abstract
An ideal in vitro model of the alveolus should reflect the physiological
microenvironment of alveolar cells, in which the cells are exposed to a complex
milieu of mechanical stimuli. Here, we describe an alveolus-on-a-chip (AOC)
device that closely mimics the structural functionality of an alveolus, including a
flexible, porous membrane that allows cell growth at air-liquid interface (ALI),
continuous perfusion, and the recapitulation of the three-dimensional (3D) cyclic
stretch induced through breathing. The device was designed so that the porous
membrane could allow nutrients to be exchanged in both static and dynamic
conditions. A fluid path was assimilated for continuous perfusion for replenishing
media for the cells. The stretching condition used in the system to apply strain on
the alveolar membrane was inspired by human breathing. The stretching method
takes advantage of the transmural pressure that occurs via the fluid flow in the
system, which results in a partial collapse of the elastic porous membrane. The
design of this device aims to imitate the mechanical microenvironment of the
alveoli, and to make the fabrication process robust. The capabilities of the alveolar
device were established by culturing adenocarcinomic human alveolar basal
epithelial cells (A549) at i) ALI, ii) ALI with continuous perfusion and iii) ALI with
continuous perfusion and cyclic mechanical stretch. These results represent the
initial steps towards the development of a next-generation alveolar platform that
can be utilized for rapid drug screening and disease study.
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Introduction
All the organs in the human body are subjected to some type of mechanical
stress. The lung is subjected to a wide variety of mechanical forces such as a)
changes in surface tension at the air–liquid interface (ALI) within the alveoli, b)
continuous blood flow in the capillaries creating shear stress on the lung
endothelium, and c) cyclic stretch due to inspiration and expiration exerting
mechanical stress on the epithelium (1, 2). These mechanical cues help regulate
the lung’s cellular morphology (3), development (4, 5) as well as the structural and
functional capacity of the mature lung (6). Studies have been reported that
conducted the influence of mechanical stimulation on the regulation of various
alveolar cellular functions such as cell proliferation (7), apoptosis (8), differentiation
(9, 10), surfactant secretion (11), cell migration (12), signal transduction (13), gene
expression (14), and ion mobilization (15) and transport (16-18).
Several Lung-on-a-Chip (LOC) models have attempted to recapitulate the
mechanical stimuli found in the lung and alveolar regions in vitro. One of the
seminal LOC models reported an exposure of 6.7 dyn/cm 2 of shear stress to rat
alveolar type II cells in in vitro conditions and showed cell viability for at least 24
hours (19). The stress was higher than the physiological equivalent shear stress
found in the capillaries, 2 - 4 dyn/cm2 (20). After 6 hours of fluid flow the cells would
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aggregate and balled up from the cell culture device indicates the inadequacy of
the system for long term cultures. The lung cells were directly in contact with the
fluid flow which is not relevant to the physiology, also the cell culture substrate was
very rigid silicon substrate (62 GPa). The work proved the proof-of-concept of a
LOC model even though it needed improvement in cell culture substrate selection,
nature of mechanical stimuli and type of cells used in the system etc. Recent
advancements have been made in LOC models that include the gradual
incorporation of different mechanical stimuli in the system.
One study performed a 5 – 12 % unidirectional mechanical stretch that was
applied to human adenocarcinoma cells (A549) in a microfluidic device by creating
a vacuum in the side chambers of the cell culture compartment (21). The
physiological level of strain in human lung is 4 – 12% in a healthy adult, can
increase up to 37 % (22). The model also featured ALI and continuous perfusion
with a fluid flow that created 15 dyn/cm 2 of shear stress. While it made several
advancements in the LOC field, this model also had several limitations. One of the
primary limitations was the nature of the stretch generated in the device. In the
human body, the expansion of the alveolus occurs due to the involuntary inhalation
of air, causing the alveoli to expand in a three-dimensional (3D) manner. The strain
in the alveolus is not uniformly distributed, and as a result, this greatly affects the
location and development of the two primary cells that reside within it (23). In
addition, since the device was a closed system, external air was artificially
introduced inside the chamber, which might not be an exact representation of
inhalation, and could jeopardize testing the effect of particles or inhaled drugs. In
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addition to that, the shear stress created on the cells was 4 times higher than the
physiological conditions. Furthermore, cyclic stretch was eliminated from the chip
in their most recent studies (24).
Another study looked at the combination of both solid and liquid stressors
in their alveolus-on-a-chip (AOC) model. This model added value to previous work
by engineering a geometrically representative alveolar structure, instead of a
channel based one that mimics the respiratory conducting airways (13). The
basement membrane was fabricated from a flexible, non-porous membrane and
was partially filled with air and liquid. The alveolar epithelial cells were subjected
to a solid mechanical stress during cyclic stretching, and fluid mechanical stresses
when the ALI meniscus exposed the alveolar cells to shearing, shear gradients,
pressure,

and

pressure

gradients.

The

researchers

established

a

microenvironment that is responsible for multiple types of stress and surface
tension related diseases (13). The presence of true ALI was absent due to a solid
non-porous membrane, and there was no continuous perfusion to mimic the
capillary fluid flow in this system (25).
In another notable study, physiologically relevant 3D mechanical strain was
mimicked by the actuation of a micro diaphragm. A pre-determined negative
pressure was created beneath the micro-diaphragm of a 40 µm thick PDMS
membrane by a custom electro-pneumatic set up, and the deflection of the
membrane caused 10% linear strain in the cell culture substrate. Even though the
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system mimicked the negative pressure breathing phenomena very closely, it did
not possess an ALI or continuous perfusion (26).
Until now, no one has attempted to combine the three most important
mechanical stimuli found in the human alveolus i.e. ALI, continuous perfusion and
3D cyclic stretch in a single AOC platform. In this chapter, research was conducted
to bring advancement to the current AOC paradigm by incorporating all these three
mechanical stimuli. The chapter describes the design of a novel microfluidic
system that enables the study of a functional alveolus by incorporating ALI,
mechanical stretch and continuous perfusion. This work presents a nonpneumatically actuated microfluidic technique for achieving cyclic stretching in the
device, which eliminates the need for extraneous pumps or vacuum sources.
Key functional differences that enable this microfluidic system to
recapitulate the alveolus include: (1) a cell culture chamber that mimics the
geometry of an alveolus, (2) a thin polymeric cell culture substrate other than
PDMS or PET that allows alveolar cell growth, (3) micropores of 5 µm diameter
with porosity of physiological relevance in the cell culture substrate that allows for
ALI, (4) flexibility of the membrane that allows for transmitting fluid stress and
mechanical stress on the alveolar epithelial cells, (5) a bottom channel underneath
the alveolar cell chamber for continuous media perfusion, and (6) the ability to
simulate breathing during the mechanical cyclic stretch. The fabrication of this
AOC model was done using rapid multi-layer lamination technique. A description
of the different aspects of the fabrication for this device are reported in this chapter.
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This chapter also presents the optimization and characterization of the
incorporation of ALI, continuous perfusion and cyclic stretch in the device. Finally,
the successful demonstration of the biocompatibility and functionality were
achieved by culturing A549 cells on the chip with all of the stated mechanical
stimuli. This advanced AOC design is a promising platform to the LOC community
because of its potential utility for screening drugs and toxic compounds, and for
studying different pulmonary diseases.

Materials and methods
5.3.1. Fabrication of the alveolus-on-a-chip
Membrane fabrication
Polyester polyol-based polyurethane (PU) membranes were produced
using the method previously described (27). A thin water soluble sacrificial layer of
polyvinyl alcohol (PVA, Fibre Glast Developments Corporation) was spin coated
at 1000 revolutions per minute (rpm) for 90 seconds on 100 mm diameter nontreated quartz wafer (Coresix Precision Glass, Inc., 7980 Fused Silica PN A0703).
Two PU components (GS Polymers, Inc., cat. number GSP 1552-2, AK-VIS
number1) were mixed together at a 1:1 weight ratio and the mixtures were poured
onto the wafer coated with PVA. Immediately after pouring, the polymer was spin
coated (Specialty Coating Systems, Inc., cat. number SCS G3) at 500 rpm for 60
seconds (s), followed by 1000 rpm for 60 s and 4000 rpm for 90 s. The coated
wafer was then cured by a thermal treatment at 83°C for 4 hours.
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Micromachining pores in PU membrane
Porous PU membrane was fabricated using the method described in our
previous work (Chapter 4). A custom-built femtosecond (FS) laser that was
designed at the Los Alamos National Laboratory, Center for Integrated
Nanotechnologies (CINT) was utilized to attain pores on the membranes. The PU
membranes that were coated on quartz wafers were irradiated with laser pulses at
a wavelength of 776 nm. A set of process parameters were selected with a
combination of 35 overlapping pulses on and 750 overlapping pulses off, 25 µJ
pulse energy, 100 kHz repetition rate and 23.35 J/cm2 of laser fluence to fabricate
4 mm fraction of porous area on PU membranes. Figure 5.1 shows the steps of
fabrication and release of the porous PU membrane.
Fabrication of the bioreactor
A rapid prototyping method based on laser based micro-patterning and
multi-layer lamination techniques (28) were used to fabricate the alveolar
bioreactor. Figure 5.2 shows the different layers and materials that were used to
assemble the AOC bioreactor. The patterns for each layer were designed using
Solid Edge 2D Drafting ST10 software (Siemens PLM Software). The design was
cut using a CO2 laser cutter (M-360, Universal Laser Systems). Four out of the
total eight layers were cut out of a 1/16” acrylic sheet (Plaskolite Optix, Columbus,
Ohio). Three of them were cut from polyethylene terephthalate (PET) (0.25 mm;
McMaster-Carr, Elmhurst, IL). The porous membrane component of the bioreactor
was fabricated in house as described in the previous section. For lamination
purposes, adhesive transfer tapes (9122, 3M Company) were transferred on layers
140

1, 2 and 7 on one side, and layers 4 & 6 on both sides, respectively. After all of the
device layers were cut, they were then cleaned via sonication in distilled water for
10 minutes. Post sonication, the layers were dried in a stream of compressed air
to remove any residual particulate debris generated by the laser cutting process.
Integrating the device
The porous PU membranes were cured for approximately one hour at 80ºC
after the pore micromachining. A previously cut PET layer with one side adhesive
and a 4 mm hole in the center was then laminated onto the PU membrane. The
PET frame was placed in such a way so that the hole can cover the 4 mm porous
area on the membrane. A knife was used to lightly score around the frame. The
wafer along with the frame was then submerged in water overnight to dissolve the
PVA layer that was initially coated underneath the PU membrane. The porous
membrane attached to the PET frame was then lifted and released from the wafer
(Figure 5.1). After preparing all of the components for the AOC device, they were
manually assembled to obtain the final bioreactor. The top most acrylic layer was
designed to have access holes for the insertion of inlet and outlet nodes to the
chamber that houses the porous membrane. Two series barbs (BDMR210 – 9002,
Nordson Value plastics) were attached on the inlet and outlet and sealed with UVcurable glue (Dymax, CT, USA), Digital Syringe Dispenser (Dymax, CT, USA),
Medical Device Adhesive (Dymax, CT, USA). A fluid media reservoir was made
and connected via a 1.3 mm internal diameter (ID) tube to the input node on the
AOC device. Another tube was connected from the output node to the reservoir
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through a peristaltic pump. A constriction with 0.5 mm ID was placed between the
input tubing from reservoir to input mode (Figure 5.3).
5.3.2. Device characterization
Bulging height
The deformation properties of the porous membrane were compared to the
non-porous membrane by utilizing bulging technique described in Chapter 3 (29).
Both porous and non-porous membranes were integrated into the microfluidic
bulging test unit. The test unit (Figure 5.4A) was designed such that a given
constant pressure could be applied on the 10 µm thick PU membrane placed on a
4 mm diameter opening. Each unit was placed in a vertical position (Figure 5.4B)
so that the bulge can be observed through the microscope (Stereo microscope,
AmScope). Constant pressure was applied by using a pneumatic pump
(PneuWave, CorSolutions). The bulge height was observed and captured by
image processing software (uEye, IDS Imaging Development Systems GmbH).
Each image was manually analyzed to measure the bulge heights (Figure 5.4C)
against a ruler imaged with the same magnification and compared.
Surface area change
The strain properties of the alveolar device were characterized by a
modified bulge test, described in detail by our previous work (22, 30). To perform
the bulge test, individual non-porous membranes were mounted onto a test
alveolar unit. The test unit was designed such that, the deformation of the nonporous PU inside the alveolar chamber can be measured by the change in fluid
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volume. The alveolar device was closed from the top and connected to a two-part
microfluidic ruler device that has a microchannel with a centimeter scale engraved
adjacent to it. The bottom chamber of the device was filled with DPBS. The top
chamber and the microchannel ruler device was filled with fluorinated oil. By
running a fluid with a determined flow rate, it was possible to create an inward
bulge inside the alveolar device, which then displaced the length of the oil inside
the ruler device. Each unit was placed so that the length of the oil change can be
observed through the microscope (Stereo microscope, AmScope). Various rpms
(0.1 to 25) that corresponds to various flow rates (48 – 2780 µl/min) were applied
using the peristaltic pump (PneuWave, CorSolutions). The displaced oil lengths
occurred the volume change length were captured by image processing software
(uEye, IDS Imaging Development Systems GmbH). Each image was analyzed
manually to measure the length change that is responsible for volume change in
the device. The bulging volume (V_sp) is equal to the displaced oil volume (∆l
×h×w) where h is the height of the microchannel and w is the width). If Vsp was
assumed to have a spherical cap, it may be represented by equation (1) where r
is the radius of opened window for bulging membrane:
𝟏

𝑽𝒔𝒑 = 𝟔 𝝅𝒘𝟎 (𝟑𝒓𝟐 + 𝒘𝟎 𝟐 )......................................................................................... (5.1)
The change in length along the ruler may then be correlated to volumetric
displacement due to the membrane bulging. In equation (2), the change in length
of displaced fluorinated oil along the ruler is denoted as ∆l and the change in height
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of the membrane is denoted as w0. The bulging height can then be calculated using
the length of the displaced fluid using the following:
∆𝒍 =

𝑽𝒔𝒑
𝒘𝒉

𝝅

𝟐

= 𝟔𝒘𝒉 𝒘𝟎 (𝟑𝒓𝟐 + 𝒘𝟎 ) ................................................................... (5.2)

Figure 5.5A shows the device set up and 5 B) and C) are two images that
shows experimental oil length (∆l) due to flow rate change in the scale device. The
bulging height for different flow rates were then calculated using equation 2. The
surface area of the spherical cap with this wo may be calculated using the equation
(3):
𝟐

𝑺𝒄𝒂𝒑 = 𝝅(𝒓𝟐 + 𝒘𝟎 ) .................................................................................................... (5.3)
The strain for a given flow rate was calculated by using the percent surface
area change due to flow rate (Figure 5.5D). Using the same configuration, the flow
rate was measured for various flow rate to correlate the strain to the flow rate
shown in Table 5E.
5.3.3. Cell culture in the device
Device preparation for cell culture
Assembled devices were washed with DPBS, followed by 200 µL of 5%
hydrogen peroxide that was added to the bottom chamber and 80 µL of same
solution added to the top chamber of the AOC device. The AOC device was then
UV-sterilized (280 nm) in a UV-Stratalinker 1800 (Stratagene California, CA, USA)
for 30 minutes. Following sterilization, hydrogen peroxide was removed, and
devices were plasma treated (Harrick Plasma, NY, USA) at high settings for two
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minutes. A collagen gel of 50 µg/ml rat collagen (Corning Inc., NY, USA) was
prepared using 1N sodium hydroxide to bring the solution to pH 7. Devices were
then incubated with the gel in the top chamber at 37 °C for 4 hours. Excess coating
solution was aspirated off. Finally, all the devices were rinsed one more time with
sterile DPBS and stored in a refrigerator until cells were ready to be seeded.
Cell culture in the device
The devices were allowed to reach room temperature from the refrigerator.
Cell culture medium was then added to the top and bottom chambers and kept in
incubator at 37°C overnight. The next day, A549 cells were seeded on the top
chamber with a cell density of 1.6 x 106 cells/cm2. Cells were grown for two days
until they reached confluency, and then were either 1) kept submerged for total 7
days, 2) exposed to ALI on day 2 and cultured for 5 days, 3) exposed to ALI on
day 2 and cultured at ALI with continuous flow for 5 days and finally, 3) exposed
to ALI on day 2 and kept at ALI with continuous flow but no stretch till day 5 and
exposed to cyclic mechanical stretch for 48 hours (Figure 5.6).
Stretching protocol
A stage for alveolar device was made using a combination of acrylic and
stainless-steel hardware. A peristaltic pump (ARCUS) and reservoir holder were
both integrated in the stage design. The device was placed on top of the stage and
connected to the reservoir through the peristaltic pump (see schematic Figure 5.3).
A constriction was used between the reservoir and input port on the device. This
created a negative pressure inside the device that resulted in an inward bulge of
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the membrane layer. Using a custom build software (ATHENA 0.1.0.b) it was
possible to create and run a script for the pump to follow.
Cell staining for cytoskeleton
Cells grown in AOC device were stained for the cytoskeleton proteins (i.e.
actin). Image-iT™ Fixation/Permeabilization Kit (Thermo Fisher Scientific. MA,
USA) was used to fix and permeabilize the cells. ActinGreen™ 488
ReadyProbes™ Reagent (Thermo Fisher Scientific. MA, USA) was prepared in
DPBS buffer according to manufacturer’s instructions. The nuclei counterstaining
NucBlue™ Fixed Cell ReadyProbes™ reagent (Thermo Fisher Scientific. MA,
USA) was added to the same buffer (1 drop / mL). Fixed cells were incubated with
buffer containing Actin antibody and Nucblue for 24 hours at 4 °C in the
refrigerator. The following day, the cultures were washed three times with DPBS
and the membranes from the inserts were carefully cut out with a knife. The
membranes were mounted on a glass slide using ProLong™ Diamond Antifade
Mountant (Thermo Fisher Scientific. MA, USA). The specimens were then
observed using a fluorescent microscope (Carl Zeiss AG, Germany), software ZN
292 (1.1.1.0). The excitation and emission wavelengths used for ZO-1 were 495
and 519 nm, and for NucBlue were 360 and 460 nm.

Results and discussion
A 10 ± 2 µm thick flexible PU membrane was obtained by using the spin
coating process. Pores with an average diameter of 5 - 7 µm were created in the
membrane at a density of 60,000 pores/ cm 2 using a femtosecond laser. The
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average 5 - 7 µm pore size allowed for efficient nutrient transfer to support cell
growth at ALI shown previously (Chapter 4). The total area covered by the pores
closely aligned with the physiologically relevant values (kohn pores in alveolar wall
covers 0.016 cm2 area/ cm2 whereas micromachined pores in PU covers 0.016
cm2 area (31)). The release of the porous membrane from the quartz wafer was
simplified by the addition of releasing PVA layer. Because the PVA dissolves very
quickly in water, the membrane fully released within 4-5 minutes. The final AOC
device design was a product from many iterations to improve the cell seeding, and
media replenishment processes. The final iteration also helped minimize the
formation of bubbles within the system. The rapid multi-layer-lamination
techniques that were employed in this study to fabricate AOC microfluidic device
helped facilitate fast and cost-effective prototyping, utilization of cheap
biocompatible materials, full access to spontaneous design alterations as well
development of as an easily controllable microenvironment that is suitable for the
cell culture.
The AOC devices were further characterized for mechanical properties that
were relevant to our study. The elastic membrane inside the alveolar device
deforms when there is a fluid flow. The exact mechanism responsible for this
phenomenon is not fully understood, as it is composed of a great level of dynamic
complexity. A simplified explanation has been reported by solving Navier-Stokes
equations governing fluid motion in a channel with an elastic boundary (32). The
Navier-Stokes equations describe the motion of fluids and is an adaptation of
Newton's second law for fluids. In a simplified explanation, a pressure change will
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occur due to the fluid density and fluid velocity when the fluid is flowing through a
channel that has an elastic wall in a two-dimensional space. The elastic wall will
also exert force on the fluid depending upon its tension properties. As a result, the
membrane will bulge inward or outward due to the net pressure differential. Figure
5.7 presents the schematic of the proposed non-pneumatic stretching platform
incorporating microfluidic aspiration. The platform has two nodes for injecting and
withdrawing fluid. Pulling media through the inlet to the outlet can produce a low
transmural pressure inside the media chamber. When the cell compartment is
maintained at atmospheric pressure, this pressure drop causes the membrane to
deform and bulge inward inside the media chamber. We designed the flow path
with a constriction so that it can enhance the bulge and direct the pressure drop
inside the chamber during the pulling of fluid. By pausing the flow in a cyclic fashion
and letting the elastic membrane relax, a cyclic stretch can be applied to the
substrate. The position of the constriction is also carefully considered when
designing the fluid path. If it is too close to the inlet node, it can cause an unwanted
pressure to drop. This can cause the air to permeate inside the media chamber
through the pores and produce bubbles. Optimum negative pressure induced
actuation of the membrane can be obtained by placing the constriction 4 mm from
the reservoir in our current system. By regulating flow in the media chamber, the
strain on the membrane can be optimized to achieve a desired strain condition.
Our device is, to our knowledge, the only alveolar device utilizing this phenomenon
to achieve alveolar stretching.
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To achieve the desired strain profile of the AOC device we used an in-house
built microfluidic bulging device to calculate the volume displacement for varied
pump flow rate. A non-porous PU membrane was used since a porous membrane
is not suitable for using in this device to measure strain. Prior to this strain-profiling
experiment, we compared the deformation of both porous and non-porous PU by
applying air-pressure using a different microfluidic device. We observed that the
presence of pores in PU does not really change the elastic properties of the
membrane with the applied pressure within our scope, and the deformation
behavior is very similar to non-porous PU (Figure 5.4). We assume that the pore
(5 µm) size and the area (0.016 cm2/cm2) covered by the pores has very negligible
effect on changing the membranes stiffness properties. This data suggests that
non-porous PU can be used to obtain the strain profile for AOC device integrated
with porous PU.
Non-porous PU was integrated in a modified AOC device and change in
surface area was calculated from the obtained volume displacement information
from the device. The strain data helped determining the required flow rate needed
to operate the AOC device to obtain physiologically relevant strain on the cells. For
our study, we chose to work with 1% strain to validate the device functionality.
A549 cell lines were employed for our initial assessment of cell growth
characteristics in the AOC device because of their culture robustness and
reproducibility.
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First, we characterized the AOC device for culturing cells under ALI
conditions. Exposure of the apical surface of alveolar epithelial cells to ALI
increases oxygen availability, exerts surface tension and are crucial for promotion
and maintenance of type II cell differentiation with regard to cellular morphology,
surfactant expression etc. (33-35). The surface tension results from ALI condition
influences alveolar type II cells to produces surfactant which reduces the surface
tension to prevent alveolar collapse (36). Without ALI, it is not possible to
investigate the native state. Our result shows healthy and live cells after exposing
the cells to ALI conditions. Cells grown at ALI displayed different morphologies and
less cell layers than cells in submerged condition (Figure 5.6A and B). This
suspected phenomenon can be clarified in future work by measuring the cell layer
thickness and by looking at cell cytoskeleton. The culture was maintained for at
least 7 days at ALI, which demonstrates the long-term utility of this device.
Next, we investigated the device for continuous perfusion ALI conditions.
Several AOC models (25, 26, 37, 38) failed to simulate this stimulus at ALI
condition, as it is difficult to control fluid transport through the micropores without
flooding or drying up the cell culture chamber. We previously demonstrated a
reproducible technique to create 5 µm pores in a flexible PU membrane. In this
chapter, we describe the device condition to create continuous perfusion while the
cells are at ALI. In our preliminary set up, the constriction was very close to the
input node, which was causing flooding, bubbles and drying up of the media unenabling the continuous perfusion at ALI. After several attempts of re-positioning
the constriction, we were able to achieve the optimal conditions to create ALI with
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continuous perfusion. The advantage of maintaining continuous perfusion is that it
will continuously replace any nutrient deficient media with the fresh media.
Continual replenishment of nutrients also helps recapitulate physiological
conditions found within the human body. Moreover, the continuous perfusion
mimics the flow found in capillaries, which exerts shear stress on the cells. Figure
5.8C shows a distinct morphology of A549 cells due to being exposed to flow. The
cells were more likely to re-arrange themselves into a thin layer after the
mechanical cues have been experienced. Similar morphological effect and
influence on surfactant secretion by alveolar cells due to direct shear stress (flow
100 µL/ min) has been reported (39). But investigating the cellular functions at ALI
with continuous perfusion in a long-term culture will give a better insight
understanding pulmonary biology. This cellular morphological trigger will not only
advance the LOC community, but the other in vitro OOC systems that require the
use of a porous, soft, biocompatible membrane for cell culture or co-culture of more
than one types of cells and require continuous perfusion such as capillaries.
Finally, we investigated the device capability of creating strain on the cells.
In this study we tested the device with 1% strain from the strain profile that we
have characterized here. The focus of this study was to create a microfluidic cell
culture device for alveolar cells. Therefore, we chose to emulate the negative
pressure breathing pattern in order to create cyclic mechanical strain on the porous
membranes, cells and tissues. By manipulating the peristaltic pumps with a custom
software, we were able to manually write a script for controlling the flow operation.
The script exerted a 1% mechanical strain on the porous PU membrane at 12
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cycles/minute. It was shown to achieve mechanical strain and effect of strain on
cell functionality in a microfluidic device before. However, none of the existing LOC
devices are able to successfully assimilate three of these mechanical stimuli in one
device while running at the same time. We were able to show a healthy population
of live cells after 24 hours of the operation. We noticed that cultured cells exhibited
similar morphology to the ones in ALI with continuous flow. However, clear
qualitative differences between these four experimental conditions could not be
assessed as A549 cells do not exhibit contact inhibition and they stacked on each
other. The cells form fused cell layers in presence of flow and flow with stretch
condition which limits clear staining and visualization. We assume that cell
responded to the mechanical cues by rearranging their shape into more flattened
phenotype and fuse with each other (40). In This study can be extended to
investigate effect of strain on primary cells in a long-term culture. The
advancement made in this AOC platform can also be transferrable to other organ
mimetic platform such as gut-on-a chip, heart-on-a-chip and skin-on-a-chip etc.

Conclusions
Developing an accurate mechanical microenvironment in an in vitro
experimental model mimicking the human alveolar system is of high importance
for pulmonary drug screening and disease study. This work established a
functional device that captured the mechanical stimuli of the alveoli in a strategic
and systemic way. The functionality of the AOC device was validated by carrying
out by adapting the mechanical microenvironment individually and in combination
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with the presence of cells. The unique platform reported here has the potential to
contribute towards understanding cellular behavior and physiological processes in
alveoli. For future enhancements, these platforms will need further validation of
cell performance at higher mechanical strain levels and adding vascularization or
lung microvascular endothelial cells on the opposite side of the alveolar epithelial
cells. Optimization of the fluid flow for endothelial cell monolayer formation will be
needed. In addition, significant research is still required to incorporate primary
alveolar cells and maintain their functionality along with all the mechanical stimuli.
The applications of this miniaturized AOC system could be extended for building a
next generation lung-on-a-chip for rapid drug screening, and pulmonary disease
research.
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Figure 5.1. Schematics of the fabrication process of porous polyurethane
(PU).
A) Untreated quartz wafer was used as a substrate; B) A sacrificial PVA
layer was spin-coated onto a quartz wafer; C) Two components of PU polymer
were mixed and poured on quartz coated with polyvinyl alcohol (PVA). The thin PU
membrane was then spin coated on top of the PVA releasing layer; D) PU
membrane was patterned by an array of pores using femtosecond laser with
optimized parameters; E) PET frame with adhesive on one side laminated on
porous PU; F) PET laminated membrane on the wafer was submerged under
water. A knife was then used to score around the edges of the PET frame. PVA
dissolves in water and releases porous PU that is attached to the PET frame; G)
Porous PU on PET frame.
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Figure 5.2. Schematics of the alveolar-on-a-chip (AOC) device.
A) Various parts and materials that were used in the AOC device; B) Image
of a assembled device; C) Cross-sectional image of the AOC device showing the
media flow path; D) Magnified view of the AOC device cell culture chamber
showing porous polyurethane (PU) membrane.
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Figure 5.3. Alveolar-on-a-chip (AOC) platform set up.
A) The fluid path of the system. The fluid flow is controlled by a computer
that is connected to the pump (1). The fluid from the reservoir (2) is fed through
the constriction (3) and then connected to the input node (4) of the AOC device.
The fluid then exits through the output node (5) and travels though the pump (1)
back to the reservoir (2), B) Experimental set up of the AOC device platform.
Different components of the system are numbered and highlighted.

156

Figure 5.4. Deformation behavior of porous and non-porous polyurethane
(PU) membrane.
A) Schematic showing the different layers that were assembled to obtain
the bulge test unit, B) Photograph showing the bulge test unit placed on the
microscope stage: the unit is placed such that it is possible to observe bulging with
high precision through the microscope, C) Deflected non-porous PU membrane at
10.34 kPa as observed under the microscope, D) Deflected porous PU membrane
at 10.34 kPa as observed under the microscope. These images were used to
measure the bulge height for a given pressure; (E) Graph comparing the bulge
height at a given pressure of both non-porous and porous PU membrane. (n=3).
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Figure 5.5. Strain profile of alveolar-on-a-chip (AOC).
A) Picture showing a modified AOC unit is connected to a pump and
reservoir. Another microfluidic unit or the scale unit connected to AOC by a tubing,
B) Fluid meniscus at a resting period, C) Fluid meniscus cause by volume
displacement due to 15 rpm or 1380 µL/min flow rate, D) Graph showing change
in surface area or % strain of the polyurethane (PU) membrane due to applied fluid
flow; (E) Table correlating required rpm to create physiologically relevant
(highlighted yellow) strain in the device (n=3).
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Figure 5.6. Schematics of the cell culture experiments in alveolar-on-a-chip
(AOC).
Adenocarcinomic human alveolar basal epithelial cells (A549) were
cultured in AOC device to confluency for 2 days before exposing them to air-liquid
interface (ALI) and flow and were cultured for total 5 days before exposing them to
any mechanical stretch. Schematic showing a step-by-step guideline to culture
cells in the AOC at submerged, ALI, ALI with continuous perfusion, ALI with
continuous perfusion and cyclic mechanical stretch.
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Figure 5.7. Schematics of the alveolar-on-a-chip (AOC) platform illustrating
the principle of mechanical strain occurs within the device.
A) Image showing the initial phase when the pump assisted fluid-pull take
places inside the device. During the pull phase, the amount of fluid being pulled
cannot be replaced immediately due to the constriction. This causes a pressure
drop and the stretchable porous polyurethane (PU) membrane bulges inward due
to the higher pressure on top of the membrane, B) Image shows a steady inward
bulge caused due to transmural pressure and air getting inside the cell culture
chamber, C) Image showing the initial phase when the flow is halted or paused.
The fluid flow slows down and the pressure inside the chamber increases. This
slowly pushes the stretchable porous PU outward, as well as pushes out the air
from the cell culture chamber, D) Image shows a steady pause state where the
membrane goes back to its initial resting position and transmural pressure reverts
to a negligible state.
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Figure 5.8. Validation of the alveolar-on-a-chip (AOC).
Adenocarcinomic human alveolar basal epithelial cells (A549) were
cultured to confluency for 2 days before exposing them to air-liquid interface (ALI)
and flow and were cultured for total 5 days before exposing them to any
mechanical stretch. Florescence images obtained by staining adenocarcinomic
human alveolar basal epithelial cells (A549) for live (green) and dead (red) cell
population, i) cells cultured in the AOC device at submerged conditions for 7 days,
ii) ALI in the AOC device for 5 days, iii) cells cultured at ALI with continuous
perfusion in the AOC device for 5 days, iv) cells cultured at ALI with continuous
perfusion and 1% cyclic mechanical strain for 2 days (n =1, N = 3).
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Introduction
Recapitulation of a physiologically relevant artificial alveolar-on-a-chip
(AOC) model is heavily depend upon the vigilant selection of suitable cell type from
a reliable cell source (1). Different in vitro alveolar model has been establishing to
recapitulate the human physiology and investigate the alveolar disease conditions.
However, the in vivo applicability of almost all in vitro human lung models is limited
by the use of lung epithelial cell lines (2-10) or primary lung cells from animals (6,
10, 11). Studies where primary airway or alveolar epithelial cells were used were
not investigated to identify the specific cell types (12-16).
There are two main types of alveolar epithelial cells, alveolar type I (ATI)
and alveolar type I (ATII) cells are in human alveoli. ATI cells are large squamous
cells, comprise 8% of the alveolar cells covering 95% of the alveolar surface and
through which gas exchange takes place. Seven percent of the alveolar surface is
covered by ATII cells, which make up 16% of the total alveolar cells (17). ATII cells
synthesize and secrete pulmonary surfactant, and they replenish the ATI
population when they get compromised (18, 19). Markers for ATII cells include
surfactant protein A, B, C (SFTPA, SFTPB, SFTPC), aquaporin 3 (AQP3), and
fatty acid synthase (FAS), and markers for ATI cells include aquaporin 5 (AQP5),
receptor for advanced glycation end products (RAGE) and caveolin etc (20-24).
A variety of methods for isolating human ATII cells have been published and
some of their properties have been described. However, maintenance of surfactant
protein expression in adult ATII cells has not been established. Primary ATII
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epithelial cells lose their distinctive phenotype over a period of 1–2 weeks when
cultured in vitro, as they undergo spontaneous differentiation resulting in
expression of features characteristic of ATI cells (20, 24).
To overcome these limitations, cell lines are often used as models for
primary cells. These cells are usually derived from tumor or by immortalization of
primary cells through chemical or viral modification (25). Cancerous or
immortalized cell lines are easily accessible, are easier to culture than primary
cells, are robust, have long lifespan, and produce replicable results. Lung
Adenocarcinoma H441 cells express surfactant protein SP-A and SP-B, whereas
A549 cells do not express any of the surfactant proteins nor contain a sufficient
surfactant phospholipid (26). Another source of alveolar cell line, transduced type
I (TT1) cell showed weak staining for laminar body, and express caveolin-1 at a
lower level than cultures of in vitro derived ATI cells (25). Transformed cell lines
exhibits different phenotype than original pulmonary alveolar epithelial cells
because they go through various genotypic and phenotypic modifications (1). On
the other hand, primary lung cells from animals suffer from interspecies differences
and are thus inadequate to recreate the human in vitro model of an alveolus (2729).
The goals of this study are to determine selecting a reliable cell source that
contains human ATI and ATII cells and validate their distinct functionality in an
advanced AOC device that has been described in Chapter 5. This chapter reports
strategies to identify cell source for ATI and ATII cells, detect the specific proteins
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expressed by ATI and ATII cells in an in vitro culture and finally validate an AOC
system with this cell in presence of air-liquid interface (ALI), continuous perfusion
and mechanical cyclic stretch.

Materials and methods
6.2.1. Cell culture
Human small airway epithelial cells (HSAEC - FC-0016, Lot # 1925) were
purchased as frozen primary cultures from Life line cell technology (Walkersville,
MD). They were cultured in BronchiaLife ™ Epithelial Airway Medium (BEAM - LL0023, Lifeline) recommended by the suppliers. Although HSAEC can be
maintained in culture for 5 to 6 passages using the supplier’s 1% serum medium,
all experiments presented here were performed with HSAEC that had been
passaged a maximum of 2 times to ensure no loss of phenotype. HSAEC cells
were plated at a density of 1.6 X 105 cells/cm 2. The medium was changed every
other day till they were ready for subculture. Cultures were split at 60 – 70%
confluence by Trypsin 0.05% EDTA 0.02% (CM-0017) digestion and subculture in
the same BEAM medium. Cells were observed daily using an EVOS microscope
(XL Core).
6.2.2. Porous and Non-porous device fabrication
The AOC device was integrated as it is described in Chapter 5. Briefly, A 8
layers microfluidic AOC device was built with spin coating, femtosecond
micromachining, laser based micro-patterning and multi-layer lamination
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techniques (30). A 10 µm thick cell culture substrate was made out of two-part
polyurethane (PU) component via spin coating. The membranes were then
micromachined with femtosecond lasers to create 5 µm pores with a density of
60,000 pores/cm2. Rest of the layers of the AOC device were patterned using Solid
Edge 2D Drafting ST10 software (Siemens PLM Software) and cut using a CO2
laser cutter (M-360, Universal Laser Systems). The layers were then laminated on
top of each other with the help of adhesive transfer tapes (9122, 3M Company).
The layers were designed in such ways that the integrated device can have a cell
culture chamber, media chamber, inlet node and outlet node for fluid path (Figure
5.2). The non-porous PU membrane integrated devices were kept static and did
not get connected to any media reservoir or pump (Figure 3.1). The porous PU
integrated devices were connected to a 5 ml media reservoir and a peristaltic pump
(Figure 5.3).
6.2.3. Device sterilization
Device parts were wiped with Isopropyl alcohol (IPA) and cleaned with
sonicator (HB36, Kendal, NY, USA) before lamination. Then the integrated devices
were sterilized with a combination of 5 % hydrogen per oxide (Millipore Sigma,
Burlington, MA) and UV-Stratalinker 1800 (Stratagene, San Diego, CA) for 30
minutes. Then they were treated with oxygen plasma (Harrick Plasma, Ithaca, NY)
for 2 minutes. Membranes were then coated with either Rat tail collagen I (Corning,
NY) or Rat tail collagen I gel at a concentration of 50 μg/ml for four hours followed
by Dulbecco’s Phosphate Buffered Saline (DPBS) (Gibco by Life Technologies,
Carlsbad, CA) rinsed and stored in refrigerator submerged in DPBS solution.
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6.2.4. Cell seeding in the device
Both porous and non-porous AOC devices were allowed to reach to room
temperature from the refrigerator. Cell culture medium was then added to the top
and bottom chambers and kept in incubator at 37°C overnight. The next day,
HSAEC cells were seeded on the top chamber with a cell density of 1.6 x 106
cells/cm2.
The cells in non-porous AOC device were cultured for 5 days at static
conditions and then stained for their marker proteins. Cells were also cultured at
the same conditions in polystyrene (PS) and 0.4 µm porous Transwell (TW)
substrate as a control.
Cells that were grown in porous AOC devices were cultured in static
conditions for two days until they reached confluency. On day 3, cells were
exposed to a flow rate of 100 µL/ minute at ALI. On day 5, cells were exposed to
1% strain at 0.2 Hz by applying cyclic mechanical stretch for 24 hours (Figure 5.3).
On day 6 cells were stained for their specific markers.
6.2.5. Immunofluorescence
Cells cultured on both porous and non-porous AOC devices, PS and TW
were fixed and processed for immunofluorescent staining when the culture
reached on day 6 and 5, respectively. The cells were washed 5 minutes with DPBS
and then fixed in 4% paraformaldedyde for 15 minutes at room temperature. After
washing with ice cold DPBS for three times, cells were permeabilized with 0.4%
Triton X-100 in PBS for 5 min. After three washes with DPBS, the cells were
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blocked with 1% bovine serum (BSA - Thermo Fisher Scientific. MA, USA) in DPBS
for 30 minutes in a humidified chamber. Cells were incubated with indicated
primary antibodies overnight at 4°C, washed three times with DPBS, and incubated
with fluorescent secondary antibodies. Primary and secondary antibodies used in
this section are listed in Table 6.1. Fluorescent microscopy was performed using
a Zeiss microscope and the software ZN 292(1.1.1.0) Carl Zeiss microscopy
GmbH was used to take the images and they were analyzed using ImageJ
software (National Institutes of Health).
6.2.6. Real time PCR
RNAs were extracted from cells in non-porous AOC devices, PS and TW
using the RNeasy microkit (Qiagen) essentially as described by the manufacturer.
The only modification was that we doubled the 80 % ethanol was before reclaiming
the RNA from the column. This procedure was found to provide better RNA yield
and purity. All RNAs were treated with the DNase Kit (Qiagen) for DNA removal.
Quantitative real-time PCR (TaqMan® One-Step Real-Time RT-PCR; Applied
Biosystems, Foster City, CA) was performed for amplification of the genes on an
ABI 480 System. Pre-designed TaqMan® Gene Expression Assays were used for
SFTPC (Hs00951325_g1) and AQP5 (Hs00387048_m1) genes. Eukaryotic 18S
rRNA (Hs99999901_s1) was used as reference gene. All experiments were done
in triplicate with at least three separate different cultures. The reverse transcriptase
was performed in 25 μL reaction volumes each with 50 ng of RNA.
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Results and discussion
6.3.1. Selection of cell source
It is crucial to select a reliable source for cells that can be available
to other AOC users for the benefit of reproducibility in research. Human ATI and
ATII cells are required in order to simulate physiologically relevant AOC model.
However, the biggest drawback of culturing ATII cells in vitro is that they rapidly
transdifferentiate to ATI cells and lose their functionality (31-33). Currently, there
is no established protocol for any cell line that exhibits the full range of known type
II cell functions (31). Here we investigated several cell types from different
commercial sources for the presence of known ATII characteristics. From our
investigation we have chosen to validate our AOC model with HSAEC cells as they
are a mix population containing ciliated, clara, neuroendocrine, fibroblasts, ATII
and, ATII cells. Studies have been provided evidence that HSAEC contains cells
that shows positive markers for SFTPC protein which indicates the presence of
ATII cell in the culture (34, 35). Validating AOC system with human primary
alveolar epithelial cells will prove the proof-of-concept of this device utility in
advance pulmonary research.
6.3.2. Presence of ATI and ATII cells in the culture
Even though HSAEC has been used in one of the prior AOC model
they were not characterized for their functional proteins (12). In this study, we
investigate the presence of both ATI and ATII cells in the culture. First, we observe
HSAEC growth on non-porous PU membrane integrated in a cell culture device.
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After a period of 5 days of submerged culture we stained them for SFTPC and
AQP5 (Figure 6.1A - 1I). We compared the outcomes with cells grown on PS and
TW with the exact same conditions. From our observation we did not see any
significant difference between the ATI and ATII cell numbers (Figure 6.1J). Even
though we suspected that the substrate stiffness will make a difference on cells to
express certain protein but in our case, we did not see any and our results also
supports work that was reported by other researchers (36). We assume that it
might be possible to see the effect of substrate stiffness on cell morphology and
differentiation when a physiologically close cell substrate with stiffness 1 - 5 kPa is
used (37). We also confirmed our result by quantifying the gene expression for
SFTPC and AQP5 (Figure 6.1K). In this case, the obtained results correlated with
the prior outcome and no significant change were seen for the gene expression
across different substrates. The goal of our study was to identify ATI and ATII cell
and we successfully showed their presence in all the submerged culture.
6.3.3. Validation of a next generation AOC device with primary alveolar
cells
The robustness of an AOC device depends on certifying all its features with
primary human cells. Previously, we have successfully incorporated all three major
mechanical stimuli in a microfluidic cell culture device (Chapter 5) and validated
the device performance with adenocarcinomic human alveolar basal epithelial
cells (A549). In this chapter, we validated the device performance with HSAEC
cells. We cultured the cells in a porous AOC device for two days at submerged
culture and then exposed them to ALI with continuous perfusion for 3 days and
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finally applied cyclic mechanical stretch at 0.2 Hz for 24 hours. A static AOC device
with no fluid flow or mechanical stretch served as a control for the study. We have
stained the cells cytoskeleton cultured in both static and dynamic conditions in
order to observe the cell coverage in the device. It is challenging to acquire full cell
coverage over the entire porous membrane area, as it is possible for cells to pass
through the membrane pores. But without a fully covered area with cells the AOC
might not be functional to simulate alveolar functions. We have coated the porous
PU membrane with collagen gel to ensure maximum cell attachment and adhesion.
From our study we have found that cell covered almost 100% of the area of the
porous PU in both static and dynamic conditions (Figure 6.2). These results
validate that the AOC device supports primary cell growth in both static and
dynamic conditions.
Next, we investigated the presence of ATI and ATII cells in the culture. We
have grown the cells similar conditions as described above and stained cells for
SFTPC and AQP5 protein. Our staining results shows that both static and dynamic
culture contains ATI and ATII cells (Figure 6.3). We did not quantify any effect of
strain on the ATI and ATII cell ratio in this study. But it will be vital to quantify the
cells that represents ATI and ATII in both static and dynamic culture as the ratio of
these two types of cells governs the functionality of a healthy or diseased alveolus
(38). Our study showed viable cell population after 24 hours of cyclic mechanical
stretch exposure and showed the presence of both ATI and ATII cells in the culture.
Further we have exposed the cells to a 10% strain for 72 hours and have observed
significant cell loss in the static devices compared to dynamic devices (supporting
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information 8.). This is a great advancement in the field as no other AOC model
has shown the combination of ALI, continuous perfusion and cyclic mechanical
stretch with viable human primary cells representing ATI and ATII cells.

Conclusions
We successful validated a next generation AOC device with primary cells
that contain ATI and ATII cells. Improvement on the platform can be made by
investigating effect of different level of strain on ATI and ATII cells morphology,
differentiation and ratio. This functional AOC device can be used for rapid drug
screening and disease study.
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Figure 6.1. Presence of ATI and ATII cells in the culture.
Human small airway epithelial cells (HSAEC) cells were cultured on three
different substrates: Polystyrene (PS), Transwell (TW) and non-porous
polyurethane (PU), which were coated with the collagen type I extracellular matrix
protein. (A-C) Representative phase contrast images showing confluent cell
population on different substrates coated with collagen after 5 days,
Representative fluorescent images show HSAEC cells stained for nuclei (blue),
AQP5 (green) (D-F) and SFTPC (orange) (G-I), demonstrating the presence of ATI
(AQP5) and ATII (SFTPC) cells in the culture, J) Normalized cell density for
HSAEC cells cultured on PS, TW and PU (N = 5, n =3) (mean ± SD), K) Relative
expression levels measured by quantitative real time polymerase chain reaction
(RT-PCR). Value obtained from internal control 18s from cell cultures on PS
substrate was served as a control in this study. For each gene, N=3 and n = 3,
(mean ± SD).
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Figure 6.2. Sustainability of human primary cells in AOC device.
A) Schematic of the fluid path for the dynamic condition. The fluid travels
through the AOC device and by flowing a run and pause pattern direct by a
peristaltic pump it creates cyclic mechanical stretch on the porous PU membrane,
B) Human small airway epithelial cells (HSAEC) cells were cultured on AOC
devices integrated with porous polyurethane (PU) membrane. i) HSAEC cultured
in porous PU integrated AOC device. Cell were cultured at submerged condition
for 2 days and at ALI at static condition for 5 days. Cells were stained for actin
protein, ii) magnified view of the cells in AOC device, iii) HSAEC cells were cultured
2 days at submerged condition and then exposed to ALI with continuous perfusion
for 3 days and cyclic mechanical stretch with 1% strain at 0.2 Hz was applied to
the device for 24 hours, iv) magnified view of HSAEC cells exposed to 1% strain.
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Figure 6.3. Maintaining Alveolar type I (ATI) and Alveolar type II (ATII) cells
in the Alveolar-on-a-Chip (AOC) system.
Human small airway epithelial cells (HSAEC) cells were cultured in AOC
devices integrated with porous polyurethane (PU) membrane. Cells were cultured
at submerged condition for 2 days and either kept static and exposed to air-liquid
interface (ALI) or exposed to ALI with continuous perfusion of 100 µl/min for 3 days
and on day 5 cells were exposed to 1% mechanical strain in a cyclic fashion. Cells
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were stained for nuclei (DAPI) and ATI and ATII representative marker protein
aquaporin 5(AQP5) and surfactant protein C (SFTPC) respectively, A)
fluorescence images to identify ATI cells in both static and dynamic culture a)
images of AQP5 taken at 565 nm, b) images of DAPI at 405 nm, c) merged
overlays of the fluorescence images, B) fluorescence images to identify ATII cells
in both static and dynamic culture a) images of SFTPC taken at 565 nm, b) images
of DAPI at 405 nm, c) merged overlays of the fluorescence images. Scale bar =
20µm, N = 2, n = 1.
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Table 6.1. Primary and Secondary antibody.
Primary Antibody

Dilution

Secondary
Antibody

Dilution

Anti-Mature-SP-C
rabbit (WRAB76694-Seven hills)

1:100

1:200

Anti-Aquaporin 5
Antibody rabbit
(AQP-005-Alamone)

1: 100

1:200

555/565

ActinGreen™ 488
ReadyProbes™
Reagent (R37110Thermo Fisher
Scientific. MA, USA)
NucBlue™ Fixed
Cell ReadyProbes™
reagent (Thermo
Fisher Scientific.
MA, USA)

2
drops/ml

Goat anti-Rabbit
IgG (H+L)
Secondary
Antibody, Alexa
Fluor 555 (A21428-Thermo
Fisher Scientific.
MA, USA )
Goat anti-Rabbit
IgG (H+L)
Secondary
Antibody, Alexa
Fluor 555(A21428-Thermo
Fisher Scientific.
MA, USA )
No

Ex and Em
wavelengths
(nm)
555/565

No

495/518

No

No

360/460

1
drop/ml
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Conclusions

Introduction
A physiologically relevant in vitro human alveolar experimental model will
be a powerful tool to understand lung physiology, disease conditions as well as a
platform for rapid drug screening (1). With the growing advancement of
microfluidics technology multiple groups have been able to develop alveolar-on-achip (AOC) systems focusing on different aspects of the alveoli (2-10). However,
none of these systems could combine the major physiological features of human
alveoli. This work addresses some of the major limitations of the current AOC
systems and demonstrates the design and fabrication of an AOC system which
combines several microfluidics technologies that can be adapted for a scalable
production of these systems. The major advancements and future directions in this
work are summarized in following sections.

Developing a polymeric membrane that simulates the artificial alveolar
wall
7.2.1. Major contributions
To simulate the human alveolar wall it is crucial to choose a material that is
biocompatible, flexible and suitable for utilizing in drug screening work. The current
membranes used in AOC are either polydimethylsiloxane (PDMS) or polyethylene
terephthalate (PET). Both have their limitations in terms of small molecule
absorption (11) and capability of flexibility, respectively. Polyurethane (PU)
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membrane was developed for this work, which is biocompatible, does not absorb
small molecules and has a Young’s modulus of 13.7 MPa (12). The utilization of
PU in a microfluidic cell culture chamber for growing cells was also demonstrated.
Less absorption of small molecule, impermeability to gas, higher hydrophilicity and
flexibility make PU membrane an excellent candidate for cell and tissue
engineering research over PDMS (13) and PET (14).
7.2.2. Future improvements
Thickness
The membrane thickness obtained in this study was 10 µm, whereas the
cell basement membrane for alveoli is close to 200 nm (15). It is desirable to attain
physiologically relevant thickness in the AOC chip. Thickness of the PU membrane
can be optimized in several ways such as optimizing the spin coating method,
optimizing the viscosity of PU used in this study or optimizing the ratio of two PU
components that were used in a 1:1 ratio. The solution for handling of thinner
membrane than 10 µm was also described in this study. The PET frame lamination
method developed in this work, allows for management of fragile and thin
membranes simple and easy.
Stiffness
The elastic modulus of lung tissue is 5 kPa, whereas the reported PU
membrane has an elastic modulus 13 MPa (16). The stiffness of PU can also be
modified by changing the thickness of the membrane. Another alternative is to
change the polyisocyanate (component one) and polyol (component two) ratios
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during the mixing. In order to produce a softer and more flexible membrane, polyol
should be kept constant and the quantity of polyisocyanate should be varied and
decreased. By generating a less stiff material will make the PU membrane more
physiologically relevant for AOC systems, as the stiffness of the alveolar basement
membrane ranges from 1 – 5 kPa (14, 16). The strain profile will also change due
to the change of the stiffness as it depends on the degree of cross-linking of the
polymer (17). A decreased pressure will be required to obtain desired surface area
change for a softer membrane. On the other hand, by reversing the ration it will be
possible to obtain a stiffer material (18) which can be useful for stiffer organ
mimetic studies like bone in gigapascal stiffness range (19).

Fabricating pores in the flexible membrane to mimic physiologically
relevant environment for alveolar cells
7.3.1. Major contributions
The main role of alveoli is to exchange gas. In order to recapitulate this
milieu it is important to create micron sized pores in the cell culture substrate used
in AOC so that it can support alveolar cell growth at air-liquid interface (ALI).
Current techniques available to create micron size pores are not suitable for large
scale production. This thesis addresses the major limitations and optimizes a
femtosecond laser technique to machine 5 µm pores in PU membranes. The
technique conveys advantages by reducing the machining time, making the
process simple by offering a one-step automated process. The utilization of the
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membrane to simulate the function of an alveolar-capillary barrier proves its utility
in AOC platform as well as other tissue-barrier engineering platform.
7.3.2. Future improvements
Smaller pores
The alveoli possess close to 2 µm size pores called Kohn pores (20), which
allow immune cells to migrate from one side of the membrane to another. The
machined micropores reported in this work are in the same order of magnitude as
the physiological pore size. The present porous membrane can be utilized to study
drug

permeability,

cell

migration,

cell-to-cell

contact

and

other

useful

physiologically important events. One of the limitation of this study was the inability
to keep endothelial and epithelial cells separated as they would migrate from one
side to another through the pores. This limitation can possibly be overcome by
creating smaller pores with a 1 - 2 µm diameter. One way to achieve this will be by
machining a thinner membrane with reduced overlapping pulses. By changing the
objective lens to higher magnification will also help with acquiring smaller pores as
the beam waist will narrow down.
Pattern defects
To achieve a porous area, a pattern was designed and executed by
femtosecond laser. Occasionally, mis-patterned pores or clogged pores or craters
were noticed in the membrane. Stabilizing the laser before the run or placing the
membrane carefully onto the laser stage can slightly improve this limitation.
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Checking the laser alignment before running any experiments can also help to
attain consistent results.
Fluence variation
A 23 J/cm2 fluence was used to ablate PU membrane to create pores. It is
important to mention that sometimes it was noticeable that the laser was not
machining pores even though the optimized exact parameters are being used. This
problem was solved by adding an extra step during the work protocol. Before
machining, the laser was measured to see the output energy using a voltammeter.
By adjusting the input pulse energy, it was possible to obtain 23 J/cm2 fluence and
which can help to get pores in a reproducible fashion using the same optimized
parameters.
Permeability study
The capability of the porous membrane was confirmed by observing
transport of fluorescein molecule through the membrane. It would be a useful study
to characterize drug permeability across this membrane. This can help develop a
better understanding of drug transport and drug availability through human tissue
barriers.

Engineering an artificial alveolus that mimics mechanical stimuli
7.4.1. Major contributions
Next-Generation alveolar models should mimic alveolar wall, alveolarcapillary barrier, and major mechanical stimuli in alveolus and as well as support
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primary alveolar cells in the system. Most of these breakthroughs have been
achieved in the reported AOC platform by advancing the materials, fabrication
technology, microfluidic design, and extensive research with primary cells. An AOC
device composed of two compartments was built and can incorporate ALI, fluid
mechanical stress and cyclic mechanical stress. The model was validated in a
combination of all these stimuli as well as separately. This model can bring
tremendous benefits in lung toxicity and drug screening as well as in investigating
pulmonary diseases.
7.4.2. Future improvements
Strain characterization
Human alveoli experience 4 – 12% stain in a healthy state (16). The
validation of AOC has been done with 0.1, 1, and 3% strain. It is important to
investigate the device performance at higher strain in order to employ the device
for future applications.
Shear stress and fluid flow
In physiological state alveolus are wrapped around with capillaries and they
experience continuous shear stress of > 2 dyn/cm 2 due to the blood flow (21). The
reported AOC system was not characterized for the shear stress occurs in the
media channel due to the fluid flow. Although an approximate value of 0.05
dyn/cm2 was obtained for the wall shear stress for the inlet and outlet tubing. A
thorough investigation to determine the shear stress by fluid dynamic modeling
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should be performed and the design of the media channel should be modified
accordingly to attain physiologically relevant shear stress.
Integration of sensors
It is important to examine cell culture every day in order to monitor cell
health, occurrences of contamination and to determine confluency during a longterm culture. The developed AOC device can be visualized under the cell culture
microscope which allows the user to look at cells every day. But one of the
limitation is that, there is no physical or biochemical sensors has been integrated
in this device. The physical sensors can monitor extracellular microenvironment
parameters such as oxygen, pH, and temperature (22). Without these sensors it is
difficult to predict a failure of an experiment as it is challenging to assume what
happened inside the chamber. By integrating these physical sensors will help the
researcher identify the problem that can cause the device failure.
Upgrade the lamination technique
Multi-lamination technique was employed to fabricate the AOC device.
Intermittently, leakage and bubbles were seen in the devices, which led to cell
death and failure of the systems. This can be improved by adding a sealant or
gasket to the system to provide better support and sealing.
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Establish Primary Cell Culture on the Artificial Alveolar Device
7.5.1. Major contributions
The major epithelial cell types in alveoli are alveolar type I (ATI) and type II
(ATII) cells (23). The ATI cells facilitate gas diffusion while ATII cell contribute by
producing surfactant. These cells can be distinguished by staining them for specific
markers such as aquaporin-5 (AQP5) for ATI and surfactant protein C (SFTPC) for
ATII. The culture and maintenance of these cells in their correct phenotype is
challenging as ATII transdifferentiate into ATI in in vitro culture (24, 25). This thesis
presents the investigation of Human small airway epithelial cells (HSAEC) with the
hypothesis that the mix culture of HSAEC contains ATI and ATII cells. The cells
were characterized for their representative markers and were cultured in the AOC
device. The performance of the device was validated by demonstrating the viability
of these cells under physiologically relevant mechanical stimuli. Identifying a
reliable source of primary alveolar epithelial cells will help the lung community to
move forward in numerous research avenues. Validation of the AOC with primary
cells also show promises of utilizing the system to predict drug toxicity and human
disease physiology in a reproducible manner.
7.5.2. Future improvements
The ratio of ATI and ATII
In physiological condition the alveoli possess 60% of ATII cells and 40%
ATI cells. The results shown in this thesis did not account for that ratio. It will be a
very valuable step to investigate the ratio at different condition (such as varying
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extracellular matrix, stiffness of the cell substrate, presence of mechanical stimuli,
optimized growth and differential media etc.) and determine the optimal culture
condition to advance the simulation of true alveolar physiology in a chip.
Endothelial cells
An alveolar-capillary barrier is composed of alveolar epithelial cells on the
apical side and endothelial cells on the bottom side. Human primary lung
endothelial cells were present in this work initially. However, after incorporating the
mechanical stimuli it was difficult to maintain the endothelial cells in the system,
which led us to omit the cells for this initial validation process. Adding endothelial
cells to the system eventually will add another dimension and would truly mimic
the alveolar physiology. In order to do that, it is important to investigate the range
of shear stress and shear gradient occurs in the bottom chamber of the AOC
system. Also, proper surface modification for HLMVE attachment needs to be
investigated. Finally, a media that can support both endothelial and epithelial cells
in the culture needs to be optimized.
Presence of immune cells
Alveolar macrophage resides in the surfactant layer and help protecting the
alveoli from pathogens or any foreign insults. The presented AOC system does not
have any immunity. It will be a great addition to the system when immune cells will
be added.

200

Toxicity analysis
The aim of the thesis is to build an advanced AOC chip system which can
be utilized to screen drugs and investigate disease. The validation of the system
with a known lung toxin needs to be performed to truly understand the capabilities
of this device. In order to perform the toxicity studies, it is important to optimize the
process of drug administration, sample collection and identifying end points.

Significance of this research
This thesis reports an AOC device that is anatomically and physiologically
close to physiological alveolus. Significant research is still needed to fully validate
the AOC model, but it can still provide an improved option over other existing in
vitro models towards research and clinical applications in human respiratory
disciplines. In the future, the device hold promises to make an impact in respiratory
disease research, personalized medicine development and understanding human
lung physiology. And in addition, this device may lay the groundwork for replacing
or creating alternative platforms for animal trials.
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Supporting Information

Chapter 3. Construction of an Alveolar Wall
8.1.1. Fabrication of Poly Lactic Acid (PLLA) nano-membrane
Synthetic biodegradable polymer Poly-L-Lactic Acid (PLLA) membrane is
widely used to build three-dimensional (3D) scaffold for generation of tissueengineered organs due to their good biodegradability, good mechanical properties,
and proper degradation time. The surface of PLLA membrane, however, is
hydrophobic and does not promote cell adhesion. Here, we report the fabrication
and verification of ultra-thin membranes that aim at maximizing gas transfer, cell
adhesion efficiency while minimizing membrane-blood contact area. By optimizing
the PLLA concentration, spin coating method and surface chemistry modification
we were able to show the modified membrane that are cell culture compatible.
8.1.2. Methods and materials
1. Prepare 5% by weight solution of Poly (L-lactide) Acid (PLLA) Aldrich, Cat
#81273) in dichloromethane (About 5g in 100 mL).
2. Spin coat 1% wt poly vinyl alcohol (PVA) aqueous solution at 4000 rpm for
20 seconds
3. Dispense about 200 μL (enough to cover the surface) of PLLA (Aldrich,
Cat #81273) solution.
4. Use the condition: 300 rpm for 60s already set in spin coater.
5. Heat at 80˚C for 1 hour.
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6. Keep them in small 35 mm dish for overnight, the lid should not be closed
very tightly.
7. Cut film in specific shape needed.
8. With a pipette add drop by drop water on the edge of the film.
9. When the membrane comes off, using a sterile tweezer place it on device.
10. The membrane can test under the microscope to just verify there is no
breakage, and then can transfer to device or can use for other purposes.
8.1.3. Results & Discussions
Fabricated PLLA membranes were very close in terms of mimicking the
thickness of the alveolar wall (200 nm). However, handling of the thin membrane
was not feasible, thus was not practical for large scale utilization. Moreover, the
strechability of the membrane was very poor which made the membrane not
desirable for this very application. But, it still an excellent choice for static tissue
engineering platform that needs cell culture substrate with nanometer range
thickness.
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Figure 8.1. Fabrication of Poly (L-lactide) Acid (PLLA) nanomembrane.
Fabrication

of

Poly

(L-lactide)

Acid

(PLLA)

nanomembrane.

A)

Nanomembrane with different thickness can be obtained by varying the
concentration of PLLA, B) The thickness of the PLLA membrane decreases with
increasing angular velocity of the spin coater, B) & C) ATI cells from celprogen
were seeded on polystyrene and PLLA respectively. Cells were stained for
LIVE/DEAD assay after 5 days of the culture.
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Figure 8.2. Cell culture compatibility of PU (Bayhydrol).
Image representation live (green) and dead (red) cell population of the
human adenocarcinomia cells (A549) after 5 days culture on polyurethane (PU)
membrane fabricated from Bayhydrol, (A) Cells cultured on tissue culture
polystyrene (PS) plate; (B) Cells cultured on PU membrane; The tissue culture
polystyrene (PS) plate was served as the control.
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Figure 8.3. Adenocarcinoma (A549) on polyurethane (PU) coated with
different extracellular matrix (ECM).
Human lung adenocarcinoma cells were seeded on PU coated with
collagen (A), fibronectin (B) and no coating. Cells were grown for 5 days and
stained with Live/Dead assay. Green represents live cells and red represents dead
cells. N=1. n=3.
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Figure 8.4. Polyurethane (PU) coated with different extracellular matrix
(ECM).
PU membrane were coated with 50 µg/mL collagen and fibronectin for 4
hours. The coated membranes were then imaged by using scanning electron
microscope.
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Table 8.1. Comparison between two different types of polyurethane (PU).
Properties
Polyurethane type

Bayhydrol

GSP -1552 - 2

An anionic dispersion of an Dicyclohexylmethane-4,4’aliphatic polyester urethane diisocynate and Polyol Blend
resin

in

water/n-methyl-2-

pyrrolidone
Optical visibility

Clear

Clear

Curing temperature

60°C for 8 hours

24 – 48 hours @ room
temperature

2

hours

180ºF
Film thickness

5- 8 micron

12-18 micron

Ease of handling

Frame assisted handling

Frame assisted handling
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Chapter 4. Construction of an Alveolar-Capillary Tissue Barrier

Figure 8.5. Porosity at different systems.
Porosity at different systems. Graph was plotted by calculating total area
covered by pores in human alveoli, different commercial systems, in a lung-on-achip system and in PU membrane developed at Los Alamos national laboratory
(LANL).
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Figure 8.6. Comparison of the functionality of the constructed tissue barrier
with commercial system.
Human adenocarcinoma cells (A549) cells cultured separately and with
primary human lung primary microvascular endothelial cells (HLMVE) cells at the
air-liquid interface (ALI) for 28 days. Cells were seeded on only apical or on both
apical and basal side of Transwell PET cell culture inserts with 3 µm diameter as
a control and porous PU cell culture inserts at the same density.
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Figure 8.7. Comparison of the functionality of the constructed tissue barrier
with commercial system.
After culturing the cells for 2 days in media, cells were air-lifted (ALI) (day
= 0) and grown for 28 days at ALI, (A) Electrical resistance measurement data for
cells cultured only on the apical side of the cell culture inserts, (B) Transepithelial
electrical resistance (TEER) measurement data for cells cultured on both apical
and basal side of the cell culture inserts are presented. The measurements of
TEER presented as mean ± the standard errors of three independent experiments.
To represent differences between TEER measurements between groups,
statistical analysis was performed using single factor one-way analysis of variance
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(ANOVA) with the Tukey HSD post hoc multiple comparison tests with a probability
of P < 0.05 regarded as significant (*), N=5, n=15.
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Chapter 5. The Design and Fabrication of an alveolus-on-a-chip

Figure 8.8. Cell culture compatibility of different polymer used in building
alveolus-on-a-chip.
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Figure 8.9. Biocompability of the UV-glue used in the alveolus-on-a-chip
system.
Human adenocarcinomia cells (A549) were seeded onto Polyurethane (PU)
membrane glued onto commercially available transwell system. After 24 hours of
culture cells were trypsinized and counted using a haemocytometer. The graph
showing number of cells on PU membrane that was attached to the transwell
system using different glue.
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Chapter 6. Validation of AOC model with primary alveolar cells

Figure 8.10. Human small airway epithelial cells present mix population of
cell with different morphology.
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Figure 8.11. Human small airway epithelial cell culture at air-liquid interface
(ALI).
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Figure 8.12. Human small airway epithelial cell culture with all different
mechanical stimuli.
HSAEC cells were cultured on AOC devices integrated with porous
polyurethane (PU) membrane. Cells were stained for the nucleus with DAPI. i)
Cells were cultured at submerged condition for 2 days and at ALI at static condition
for 6 days, ii) Cells were cultured at submerged condition for 2 days and at ALI at
with 100 µL/min flow condition for 6 days, iii) Cells were cultured at submerged
condition for 2 days and at ALI at with 100 µL/min flow condition for 3 days and
exposed to 4% cyclic strain at 0.2 Hz for 3 days, iv) Cells were cultured at
submerged condition for 2 days and at ALI at with 100 µL/min flow condition for 3
days and exposed to 10% cyclic strain at 0.2 Hz for 3 days. Cells were stained for
the nucleus with DAPI, scale bar = 50 µm. N = 3, n =-1.
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Figure 8.13. Bleomycin (Bm) drug response in human small airway
epithelial cells (HSAEC) and adenocarcinoma cells (A549).
HSAEC and A549 cells were seeded in a 96 well plate with the same cell
density. After 24 hours of seeding cells were exposed to the indicated
concentration of Bm. The level of LDH released from cytoplasm into the culture
media after exposure for 24 h was determined with Cytotoxicity detection kit (LDH)
from Roche. The inhibition of cell growth was expressed as percentage of
untreated control wells. All tests were performed in triplicate. Shown is one
example of five independent experiments, all with similar results. SD, N = 5, n=3.
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Additional Data. Drug toxicity

Figure 8.14. Effect of Amiodarone on human bronchial/trachial epithelial
cell morphology after 24 hours.
Images were taken by Karl-Zeiss confocal microscope at 200 X
magnification. The cell death was observed with the increase drug dose.
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Figure 8.15. Cytotoxic effects of Amiodarone (Am) in human
bronchial/trachial epithelial (HBTEC) cells.
HBTEC cells were exposed to the indicated concentration of Am. The level
of LDH released from cytoplasm into the culture media after exposure for 24 h was
determined with Cytotoxicity detection kit (LDH) from Roche. The inhibition of cell
growth was expressed as percentage of untreated control wells. All tests were
performed in triplicate. Shown is one example of three independent experiments,
all with similar results. SD, n=3.
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Figure 8.16. Cell viability after Amiodarone treatment in human
bronchial/trachial epithelial (HBTEC) cells.
HBTEC cells were exposed to the indicated concentration of Am. After
overnight exposure, cell viability was assayed with Cell Proliferation Reagent
WST-1 kit from Roche, which measures mitochondrial dehydrogenase activities of
viable cells by reducing WST- 1 to produce a yellow color formazan dye. The
viability of cell was expressed as percentage of untreated control wells. All tests
were performed in triplicate. Shown is one example of three independent
experiments, all with similar results. SD, n=3.
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Figure 8.17. Cytotoxicity of Amiodarone was measured in Human
Bronchial/Tracheal epithelial tissue.
50,000 HBTEC cells were seeded on transwell plates coated with Human
collagen type I, day 0, cells were airlifted on day 3 tissues were allowed to mature
until day 9. Cells were treated with Amiodarone (Am) for 48 hours. Am was
removed after 48 hours and tissue response were monitored until day 20. Data
presented is the cytotoxic response of HBTEC tissue measured by LDH. Vehicle
control were adjusted and ran side by side to minimize the true Am effect.
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Figure 8.18. Normalized transepithelial electrical resistance (TEER)
changes in Human Bronchial/Tracheal Epithelial (HBTEC)
Tissue exposed to Amiodarone. 50,000 HBTEC cells were seeded on
transwell plates coated with Human collagen type I, day 0, cells were airlifted on
day 3, tissue were allowed to mature till day 9. Cells were treated with Amiodarone
(Am) for 48 hours. Am was removed after 48 hours and tissue responses were
monitored until day 20. Tissues that received amiodarone decreased resistance
and increase permeability compared to no-amiodarone treatment.

228

Figure 8.19. Cell viability after Bleomycin treatment in normal human
bronchial epithelial (NHBE) cells.
Cell viability after Bleomycin treatment in normal human bronchial epithelial
(NHBE) cells. Cells were exposed to the indicated concentration of BLM. After
overnight exposure, cell viability was assayed with Cell Proliferation Reagent MTT
kit from Roche, which measures mitochondrial dehydrogenase activities of viable
cells by reducing MTT to produce a purple color formazan dye. The viability of cells
was expressed as the percentage of untreated control wells. All tests were
performed in triplicate. Two-way ANOVA measures, F > F critical, which shows the
means of the nine groups aren’t equal. Student’s t-test indicates triton X and
Media+PBS is statistically different from every other dose, n = 9. N =3).
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Figure 8.20. Cytotoxic effects of Bleomycin in normal human bronchial
epithelial (NHBE) cells.
NHBE cells were exposed to the indicated concentration of BLM. The level
of LDH released from cytoplasm into the culture media after exposure for 24 h was
determined with the cytotoxic detection kit (LDH) from Roche. The inhibition of cell
growth was expressed as a percentage of untreated control wells. n=3.
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Figure 8.21. Effect of Bleomycin in normal human bronchial epithelial
(NHBE) cells.
Images were taken by Karl-Zeiss confocal microscope at 200 X
magnification.
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Figure 8.22. Cytotoxicity of Bleomycin was measured in Human
Bronchial/Tracheal epithelial (NHBE) tissue.
50,000 Cells were seeded on transwell plates coated with Human collagen
type I, cells were airlifted on day 3, and tissues were allowed to mature until day
5. Cells were treated with BLM for 48 hours. BLM was removed after 48 hours and
tissue response were monitored until day 33. Data presented is the cytotoxic
response of NHBE tissue measured by LDH.
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Figure 8.23. Normalized transepithelial electrical resistance (TEER)
changes in Human Bronchial/Tracheal Epithelial Tissue (NHBE) exposed to
Bleomycin.
50,000 Cells were seeded on transwell plates coated with Human collagen
type I, cells were airlifted on day 3, and the tissues could mature till day 5. Cells
were treated with BLM for 48 hours, then removed after 48 hours and tissue
responses were monitored until day 33. The cultures were washed briefly in ALI
media and TEER measurements were conducted before processing the cultures
for cytotoxicity evaluation using the LDH assay. Data (n = 3) are presented as
means ± standard deviation.
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